more general categories |
information about this item |
|
1. Human Genes |
 |
 |
|
1. Human Genes |
|
|
acyl-CoA thioesterase 7 [HGNC:ACOT7] (13) |
|
|
ADP-ribosylation factor GTPase activating protein 1 [HGNC:ARFGAP1] (3) |
|
|
G protein-coupled receptor kinase interacting ArfGAP 1 [HGNC:GIT1] (2) |
|
|
aldehyde dehydrogenase 05 family, member A1 [HGNC:ALDH5A1] (15) |
|
|
aldehyde dehydrogenase 06 family, member A1 [HGNC:ALDH6A1] (27) |
|
|
aldo-keto reductase family 1, member B10 (aldose reductase) [HGNC:AKR1B10] (76) |
|
|
aldo-keto reductase family 1, member C1 [HGNC:AKR1C1] (148) |
|
|
aldo-keto reductase family 1, member C2 [HGNC:AKR1C2] (134) |
|
|
aldo-keto reductase family 1, member C3 [HGNC:AKR1C3] (128) |
|
|
euchromatic histone-lysine N-methyltransferase 2 [HGNC:EHMT2] (14) |
|
|
G patch domain and ankyrin repeats 1 [HGNC:GPANK1] (6) |
|
|
G protein-coupled receptor kinase interacting ArfGAP 1 [HGNC:GIT1] (2) |
|
|
notch 2 [HGNC:NOTCH2] (18) |
|
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [HGNC:NFKB1] (254) |
|
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [HGNC:NFKBIA] (290) |
|
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon [HGNC:NFKBIE] (19) |
|
|
uveal autoantigen with coiled-coil domains and ankyrin repeats [HGNC:UACA] (8) |
|
|
apolipoprotein L, 1 [HGNC:APOL1] (16) |
|
|
apolipoprotein L, 4 [HGNC:APOL4] (2) |
|
|
catenin (cadherin-associated protein), beta 1, 88kDa [HGNC:CTNNB1] (129) |
|
|
|
|
|
valosin containing protein [HGNC:VCP] (19) |
|
|
|
|
|
ATP-binding cassette, sub-family B (MDR/TAP), member 04 [HGNC:ABCB4] (30) |
|
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) [HGNC:TAP2] (11) |
|
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 [HGNC:ABCC1] (177) |
|
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 [HGNC:ABCC2] (152) |
|
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 [HGNC:ABCC3] (89) |
|
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 [HGNC:ABCC4] (88) |
|
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [HGNC:HIF1A] (212) |
|
|
nuclear receptor coactivator 3 [HGNC:NCOA3] (42) |
|
|
transcription factor 04 [HGNC:TCF4] (38) |
|
|
v-myc avian myelocytomatosis viral oncogene homolog [HGNC:MYC] (254) |
|
|
cAMP responsive element modulator [HGNC:CREM] (36) |
|
|
CCAAT/enhancer binding protein (C/EBP), alpha [HGNC:CEBPA] (49) |
|
|
CCAAT/enhancer binding protein (C/EBP), beta [HGNC:CEBPB] (71) |
|
|
jun D proto-oncogene [HGNC:JUND] (61) |
|
|
jun proto-oncogene [HGNC:JUN] (290) |
|
|
nuclear factor, erythroid 2-like 2 [HGNC:NFE2L2] (213) |
|
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 [HGNC:B3GNT2] (14) |
|
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) [HGNC:GCNT2] (18) |
|
|
cholesteryl ester transfer protein, plasma [HGNC:CETP] (17) |
|
|
Rho-related BTB domain containing 2 [HGNC:RHOBTB2] (5) |
|
|
carboxylesterase 1 [HGNC:CES1] (103) |
|
|
cathepsin B [HGNC:CTSB] (48) |
|
|
cathepsin D [HGNC:CTSD] (53) |
|
|
5'-nucleotidase, ecto (CD73) [HGNC:NT5E] (24) |
|
|
angiotensin I converting enzyme [HGNC:ACE] (39) |
|
|
CD082 molecule [HGNC:CD82] (12) |
|
|
chemokine (C-X-C motif) receptor 04 [HGNC:CXCR4] (92) |
|
|
immunoglobulin lambda-like polypeptide 1 [HGNC:IGLL1] (8) |
|
|
insulin-like growth factor 1 receptor [HGNC:IGF1R] (72) |
|
|
integrin, alpha 6 [HGNC:ITGA6] (39) |
|
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) [HGNC:ITGAL] (26) |
|
|
integrin, alpha V [HGNC:ITGAV] (33) |
|
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) [HGNC:ITGB3] (49) |
|
|
intercellular adhesion molecule 1 [HGNC:ICAM1] (286) |
|
|
interleukin 01 receptor, type I [HGNC:IL1R1] (52) |
|
|
interleukin 07 receptor [HGNC:IL7R] (30) |
|
|
killer cell lectin-like receptor subfamily K, member 1 [HGNC:KLRK1] (11) |
|
|
kinase insert domain receptor (a type III receptor tyrosine kinase) [HGNC:KDR] (51) |
|
|
leptin receptor [HGNC:LEPR] (17) |
|
|
mucin 1, cell surface associated [HGNC:MUC1] (36) |
|
|
plasminogen activator, urokinase receptor [HGNC:PLAUR] (52) |
|
|
platelet-derived growth factor receptor, beta polypeptide [HGNC:PDGFRB] (49) |
|
|
prion protein [HGNC:PRNP] (49) |
|
|
selectin P (granule membrane protein 140kDa, antigen CD62) [HGNC:SELP] (45) |
|
|
sialophorin [HGNC:SPN] (6) |
|
|
solute carrier family 07 (amino acid transporter light chain, L system), member 05 [HGNC:SLC7A5] (51) |
|
|
toll-like receptor 2 [HGNC:TLR2] (55) |
|
|
toll-like receptor 4 [HGNC:TLR4] (62) |
|
|
tumor necrosis factor (ligand) superfamily, member 10 [HGNC:TNFSF10] (155) |
|
|
tumor necrosis factor receptor superfamily, member 10a [HGNC:TNFRSF10A] (70) |
|
|
tumor necrosis factor receptor superfamily, member 10b [HGNC:TNFRSF10B] (124) |
|
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 [HGNC:ERBB2] (109) |
|
|
chemokine (C-C motif) ligand 02 [HGNC:CCL2] (337) |
|
|
chemokine (C-C motif) ligand 03 [HGNC:CCL3] (102) |
|
|
chemokine (C-C motif) ligand 05 [HGNC:CCL5] (141) |
|
|
chemokine (C-C motif) ligand 08 [HGNC:CCL8] (9) |
|
|
|
|
|
chemokine (C-X-C motif) receptor 04 [HGNC:CXCR4] (92) |
|
|
mannose-binding lectin (protein C) 2, soluble [HGNC:MBL2] (14) |
|
|
C-type lectin domain family 07, member A [HGNC:CLEC7A] (13) |
|
|
cyclin-dependent kinase 01 [HGNC:CDK1] (151) |
|
|
cyclin-dependent kinase 02 [HGNC:CDK2] (177) |
|
|
cytochrome b-245, alpha polypeptide [HGNC:CYBA] (40) |
|
|
cytochrome P450, family 01, subfamily A, polypeptide 02 [HGNC:CYP1A2] (466) |
|
|
cytochrome P450, family 02, subfamily C, polypeptide 09 [HGNC:CYP2C9] (220) |
|
|
cytochrome P450, family 02, subfamily C, polypeptide 19 [HGNC:CYP2C19] (172) |
|
|
cytochrome P450, family 02, subfamily D, polypeptide 06 [HGNC:CYP2D6] (200) |
|
|
cytochrome P450, family 03, subfamily A, polypeptide 04 [HGNC:CYP3A4] (612) |
|
|
cytochrome P450, family 04, subfamily F, polypeptide 12 [HGNC:CYP4F12] (9) |
|
|
cytochrome P450, family 19, subfamily A, polypeptide 01 [HGNC:CYP19A1] (210) |
|
|
cytochrome P450, family 24, subfamily A, polypeptide 01 [HGNC:CYP24A1] (58) |
|
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 [HGNC:DDX11] (9) |
|
|
dynein, cytoplasmic 1, intermediate chain 1 [HGNC:DYNC1I1] (3) |
|
|
protein phosphatase 3, regulatory subunit B, alpha [HGNC:PPP3R1] (10) |
|
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) [HGNC:RASGRP1] (27) |
|
|
chemokine (C-C motif) ligand 02 [HGNC:CCL2] (337) |
|
|
chemokine (C-C motif) ligand 03 [HGNC:CCL3] (102) |
|
|
chemokine (C-C motif) ligand 05 [HGNC:CCL5] (141) |
|
|
chemokine (C-C motif) ligand 08 [HGNC:CCL8] (9) |
|
|
chemokine (C-X-C motif) ligand 01 (melanoma growth stimulating activity, alpha) [HGNC:CXCL1] (82) |
|
|
endothelin 1 [HGNC:EDN1] (119) |
|
|
interleukin 08 [HGNC:IL8] (649) |
|
|
parathyroid hormone-like hormone [HGNC:PTHLH] (30) |
|
|
EPH receptor A1 [HGNC:EPHA1] (21) |
|
|
EPH receptor B2 [HGNC:EPHB2] (12) |
|
|
Fanconi anemia, complementation group D2 [HGNC:FANCD2] (20) |
|
|
fatty acid desaturase 2 [HGNC:FADS2] (28) |
|
|
stearoyl-CoA desaturase (delta-9-desaturase) [HGNC:SCD] (78) |
|
|
angiopoietin-like 4 [HGNC:ANGPTL4] (40) |
|
|
c-mer proto-oncogene tyrosine kinase [HGNC:MERTK] (19) |
|
|
EPH receptor A1 [HGNC:EPHA1] (21) |
|
|
EPH receptor B2 [HGNC:EPHB2] (12) |
|
|
growth hormone receptor [HGNC:GHR] (15) |
|
|
insulin-like growth factor 1 receptor [HGNC:IGF1R] (72) |
|
|
interferon gamma receptor 2 (interferon gamma transducer 1) [HGNC:IFNGR2] (24) |
|
|
interleukin 07 receptor [HGNC:IL7R] (30) |
|
|
fibulin 5 [HGNC:FBLN5] (7) |
|
|
|
|
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase [HGNC:SKP2] (54) |
|
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase [HGNC:FBXW7] (15) |
|
|
forkhead box A1 [HGNC:FOXA1] (30) |
|
|
trichorhinophalangeal syndrome I [HGNC:TRPS1] (5) |
|
|
excision repair cross-complementing rodent repair deficiency, complementation group 3 [HGNC:ERCC3] (14) |
|
|
excision repair cross-complementing rodent repair deficiency, complementation group 3 [HGNC:ERCC3] (14) |
|
|
|
|
|
glutathione S-transferase mu 4 [HGNC:GSTM4] (21) |
|
|
glutathione S-transferase pi 1 [HGNC:GSTP1] (218) |
|
|
G patch domain and ankyrin repeats 1 [HGNC:GPANK1] (6) |
|
|
|
|
|
heat shock 105kDa/110kDa protein 01 [HGNC:HSPH1] (45) |
|
|
heat shock 70kDa protein 01A [HGNC:HSPA1A] (112) |
|
|
heat shock 70kDa protein 01B [HGNC:HSPA1B] (65) |
|
|
heat shock 70kDa protein 05 (glucose-regulated protein, 78kDa) [HGNC:HSPA5] (148) |
|
|
heat shock 27kDa protein 01 [HGNC:HSPB1] (84) |
|
|
heat shock protein 90kDa alpha (cytosolic), class A member 1 [HGNC:HSP90AA1] (60) |
|
|
major histocompatibility complex, class II, DP beta 1 [HGNC:HLA-DPB1] (12) |
|
|
major histocompatibility complex, class II, DR alpha [HGNC:HLA-DRA] (23) |
|
|
|
|
|
H2A histone family, member X [HGNC:H2AFX] (129) |
|
|
|
|
|
|
|
|
homeobox A11 [HGNC:HOXA11] (6) |
|
|
POU class 2 homeobox 2 [HGNC:POU2F2] (9) |
|
|
|
|
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled [HGNC:HTR2B] (10) |
|
|
IKAROS family zinc finger 1 (Ikaros) [HGNC:IKZF1] (11) |
|
|
|
|
|
kinase insert domain receptor (a type III receptor tyrosine kinase) [HGNC:KDR] (51) |
|
|
immunoglobulin lambda-like polypeptide 1 [HGNC:IGLL1] (8) |
|
|
major histocompatibility complex, class II, DP beta 1 [HGNC:HLA-DPB1] (12) |
|
|
major histocompatibility complex, class II, DR alpha [HGNC:HLA-DRA] (23) |
|
|
c-mer proto-oncogene tyrosine kinase [HGNC:MERTK] (19) |
|
|
interleukin 01 receptor, type I [HGNC:IL1R1] (52) |
|
|
kinase insert domain receptor (a type III receptor tyrosine kinase) [HGNC:KDR] (51) |
|
|
palladin, cytoskeletal associated protein [HGNC:PALLD] (22) |
|
|
platelet-derived growth factor receptor, beta polypeptide [HGNC:PDGFRB] (49) |
|
|
trio Rho guanine nucleotide exchange factor [HGNC:TRIO] (16) |
|
|
c-mer proto-oncogene tyrosine kinase [HGNC:MERTK] (19) |
|
|
intercellular adhesion molecule 1 [HGNC:ICAM1] (286) |
|
|
interleukin 01 receptor, type I [HGNC:IL1R1] (52) |
|
|
kinase insert domain receptor (a type III receptor tyrosine kinase) [HGNC:KDR] (51) |
|
|
leptin receptor [HGNC:LEPR] (17) |
|
|
platelet-derived growth factor receptor, beta polypeptide [HGNC:PDGFRB] (49) |
|
|
integrin, alpha 6 [HGNC:ITGA6] (39) |
|
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) [HGNC:ITGAL] (26) |
|
|
integrin, alpha V [HGNC:ITGAV] (33) |
|
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) [HGNC:ITGB3] (49) |
|
|
integrin, beta 6 [HGNC:ITGB6] (28) |
|
|
interferon gamma receptor 2 (interferon gamma transducer 1) [HGNC:IFNGR2] (24) |
|
|
interferon, alpha 2 [HGNC:IFNA2] (25) |
|
|
interleukin 06 (interferon, beta 2) [HGNC:IL6] (511) |
|
|
interleukin 01 receptor antagonist [HGNC:IL1RN] (58) |
|
|
interleukin 01 receptor, type I [HGNC:IL1R1] (52) |
|
|
interleukin 02 [HGNC:IL2] (144) |
|
|
interleukin 06 (interferon, beta 2) [HGNC:IL6] (511) |
|
|
interleukin 07 receptor [HGNC:IL7R] (30) |
|
|
interleukin 08 [HGNC:IL8] (649) |
|
|
interleukin 10 [HGNC:IL10] (187) |
|
|
interleukin 15 [HGNC:IL15] (24) |
|
|
interleukin 17 receptor D [HGNC:IL17RD] (4) |
|
|
interleukin 18 (interferon-gamma-inducing factor) [HGNC:IL18] (73) |
|
|
interleukin 23, alpha subunit p19 [HGNC:IL23A] (27) |
|
|
interleukin 3 (colony-stimulating factor, multiple) [HGNC:IL3] (21) |
|
|
|
|
|
lamin A/C [HGNC:LMNA] (35) |
|
|
nuclear receptor coactivator 3 [HGNC:NCOA3] (42) |
|
|
lysine (K)-specific demethylase 4B [HGNC:KDM4B] (21) |
|
|
lysine (K)-specific demethylase 5C [HGNC:KDM5C] (2) |
|
|
euchromatic histone-lysine N-methyltransferase 2 [HGNC:EHMT2] (14) |
|
|
PR domain containing 02, with ZNF domain [HGNC:PRDM2] (21) |
|
|
Kruppel-like factor 06 [HGNC:KLF6] (56) |
|
|
lectin, galactoside-binding, soluble, 2 [HGNC:LGALS2] (15) |
|
|
|
|
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa [HGNC:SDHC] (13) |
|
|
ubiquinol-cytochrome c reductase binding protein [HGNC:UQCRB] (16) |
|
|
|
|
|
death associated protein 3 [HGNC:DAP3] (12) |
|
|
mitochondrial ribosomal protein L19 [HGNC:MRPL19] (5) |
|
|
|
|
|
mitogen-activated protein kinase 01 [HGNC:MAPK1] (651) |
|
|
mitogen-activated protein kinase 03 [HGNC:MAPK3] (644) |
|
|
mitogen-activated protein kinase 08 [HGNC:MAPK8] (234) |
|
|
mitogen-activated protein kinase 09 [HGNC:MAPK9] (121) |
|
|
mitogen-activated protein kinase 10 [HGNC:MAPK10] (25) |
|
|
mitogen-activated protein kinase 14 [HGNC:MAPK14] (162) |
|
|
mitogen-activated protein kinase kinase 1 [HGNC:MAP2K1] (106) |
|
|
mitogen-activated protein kinase kinase 2 [HGNC:MAP2K2] (71) |
|
|
mitogen-activated protein kinase kinase 6 [HGNC:MAP2K6] (48) |
|
|
mucin 01, cell surface associated [HGNC:MUC1] (36) |
|
|
|
|
|
myosin VA (heavy chain 12, myoxin) [HGNC:MYO5A] (17) |
|
|
estrogen receptor 1 [HGNC:ESR1] (506) |
|
|
estrogen-related receptor alpha [HGNC:ESRRA] (30) |
|
|
peroxisome proliferator-activated receptor delta [HGNC:PPARD] (67) |
|
|
NLR family, pyrin domain containing 12 [HGNC:NLRP12] (3) |
|
|
HtrA serine peptidase 2 [HGNC:HTRA2] (29) |
|
|
PTEN induced putative kinase 1 [HGNC:PINK1] (13) |
|
|
synuclein, alpha (non A4 component of amyloid precursor) [HGNC:SNCA] (71) |
|
|
D4, zinc and double PHD fingers, family 3 [HGNC:DPF3] (7) |
|
|
lysine (K)-specific demethylase 5C [HGNC:KDM5C] (2) |
|
|
transcription factor 19 [HGNC:TCF19] (22) |
|
|
dynamin 2 [HGNC:DNM2] (5) |
|
|
insulin receptor substrate 1 [HGNC:IRS1] (47) |
|
|
protein kinase D3 [HGNC:PRKD3] (8) |
|
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 [HGNC:RAPH1] (14) |
|
|
spectrin, beta, non-erythrocytic 1 [HGNC:SPTBN1] (28) |
|
|
poly (ADP-ribose) polymerase 2 [HGNC:PARP2] (17) |
|
|
coagulation factor II (thrombin) receptor-like 1 [HGNC:F2RL1] (38) |
|
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 [HGNC:PSMD13] (10) |
|
|
proteasome (prosome, macropain) subunit, beta type, 05 [HGNC:PSMB5] (8) |
|
|
|
|
|
protein phosphatase 3, catalytic subunit, alpha isozyme [HGNC:PPP3CA] (24) |
|
|
protein phosphatase 2, regulatory subunit B, alpha [HGNC:PPP2R2A] (14) |
|
|
protein phosphatase 3, regulatory subunit B, alpha [HGNC:PPP3R1] (10) |
|
|
protein phosphatase 4, regulatory subunit 1 [HGNC:PPP4R1] (6) |
|
|
|
|
|
|
|
|
protein tyrosine phosphatase, non-receptor type 06 [HGNC:PTPN6] (20) |
|
|
protein tyrosine phosphatase, non-receptor type 11 [HGNC:PTPN11] (14) |
|
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 [HGNC:PTPRN2] (12) |
|
|
dual specificity phosphatase 13 [HGNC:DUSP13] (8) |
|
|
dual specificity phosphatase 23 [HGNC:DUSP23] (10) |
|
|
|
|
|
structural maintenance of chromosomes 3 [HGNC:SMC3] (17) |
|
|
RAB05A, member RAS oncogene family [HGNC:RAB5A] (12) |
|
|
trio Rho guanine nucleotide exchange factor [HGNC:TRIO] (16) |
|
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha [HGNC:PPARGC1A] (87) |
|
|
polypyrimidine tract binding protein 1 [HGNC:PTBP1] (13) |
|
|
serine/arginine-rich splicing factor 01 [HGNC:SRSF1] (25) |
|
|
transformer 2 alpha homolog (Drosophila) [HGNC:TRA2A] (22) |
|
|
ribosomal protein S19 [HGNC:RPS19] (16) |
|
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase [HGNC:CHFR] (11) |
|
|
serine/arginine-rich splicing factor 01 [HGNC:SRSF1] (25) |
|
|
|
|
|
HtrA serine peptidase 2 [HGNC:HTRA2] (29) |
|
|
protease, serine, 02 (trypsin 2) [HGNC:PRSS2] (11) |
|
|
serpin peptidase inhibitor, clade B (ovalbumin), member 02 [HGNC:SERPINB2] (63) |
|
|
protein tyrosine phosphatase, non-receptor type 06 [HGNC:PTPN6] (20) |
|
|
protein tyrosine phosphatase, non-receptor type 11 [HGNC:PTPN11] (14) |
|
|
SHC (Src homology 2 domain containing) transforming protein 1 [HGNC:SHC1] (29) |
|
|
signal transducer and activator of transcription 3 (acute-phase response factor) [HGNC:STAT3] (145) |
|
|
signal transducer and activator of transcription 6, interleukin-4 induced [HGNC:STAT6] (32) |
|
|
suppressor of cytokine signaling 3 [HGNC:SOCS3] (46) |
|
|
v-crk avian sarcoma virus CT10 oncogene homolog-like [HGNC:CRKL] (18) |
|
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog [HGNC:LYN] (39) |
|
|
solute carrier family 02 (facilitated glucose transporter), member 03 [HGNC:SLC2A3] (76) |
|
|
solute carrier family 07 (amino acid transporter light chain, L system), member 05 [HGNC:SLC7A5] (51) |
|
|
solute carrier family 22 (organic anion transporter), member 08 [HGNC:SLC22A8] (42) |
|
|
solute carrier family 31 (copper transporter), member 1 [HGNC:SLC31A1] (35) |
|
|
SRY (sex determining region Y)-box 08 [HGNC:SOX8] (7) |
|
|
EPH receptor A1 [HGNC:EPHA1] (21) |
|
|
EPH receptor B2 [HGNC:EPHB2] (12) |
|
|
stromal interaction molecule 2 [HGNC:STIM2] (6) |
|
|
structural maintenance of chromosomes 1A [HGNC:SMC1A] (20) |
|
|
structural maintenance of chromosomes 3 [HGNC:SMC3] (17) |
|
|
sulfotransferase family 4A, member 1 [HGNC:SULT4A1] (9) |
|
|
suppressor of cytokine signaling 3 [HGNC:SOCS3] (46) |
|
|
CD082 molecule [HGNC:CD82] (12) |
|
|
FK506 binding protein 05 [HGNC:FKBP5] (46) |
|
|
tetratricopeptide repeat domain 39A [HGNC:TTC39A] (6) |
|
|
tropomyosin 1 (alpha) [HGNC:TPM1] (32) |
|
|
tubulin, beta 2A class IIa [HGNC:TUBB2A] (21) |
|
|
tubulin tyrosine ligase-like family, member 12 [HGNC:TTLL12] (10) |
|
|
lysine (K)-specific demethylase 4B [HGNC:KDM4B] (21) |
|
|
serine/threonine kinase 31 [HGNC:STK31] (2) |
|
|
tumor necrosis factor [HGNC:TNF] (795) |
|
|
tumor necrosis factor (ligand) superfamily, member 10 [HGNC:TNFSF10] (155) |
|
|
tumor necrosis factor receptor superfamily, member 10a [HGNC:TNFRSF10A] (70) |
|
|
tumor necrosis factor receptor superfamily, member 10b [HGNC:TNFRSF10B] (124) |
|
|
voltage-dependent anion channel 1 [HGNC:VDAC1] (19) |
|
|
dynein, cytoplasmic 1, intermediate chain 1 [HGNC:DYNC1I1] (3) |
|
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase [HGNC:FBXW7] (15) |
|
|
phospholipase A2-activating protein [HGNC:PLAA] (10) |
|
|
protein phosphatase 2, regulatory subunit B, alpha [HGNC:PPP2R2A] (14) |
|
|
transducin (beta)-like 1X-linked [HGNC:TBL1X] (19) |
|
|
|
|
|
early growth response 1 [HGNC:EGR1] (140) |
|
|
IKAROS family zinc finger 1 (Ikaros) [HGNC:IKZF1] (11) |
|
|
Kruppel-like factor 06 [HGNC:KLF6] (56) |
|
|
MYC-associated zinc finger protein (purine-binding transcription factor) [HGNC:MAZ] (12) |
|
|
trichorhinophalangeal syndrome I [HGNC:TRPS1] (5) |
|
|
Wilms tumor 1 [HGNC:WT1] (27) |
|
|
zinc finger protein 023 [HGNC:ZNF23] (6) |
|
|
|
|
|
zinc finger, CCHC domain containing 2 [HGNC:ZCCHC2] (25) |
|
|
DEAF1 transcription factor [HGNC:DEAF1] (12) |
|
 |
2. Interaction: Human Genes and Chemicals |
 |
 |
|
2. Interaction: Human Genes and Chemicals |
|
|
binding (2423) |
|
|
cotreatment (1499) |
|
|
expression (494) |
|
|
localization (731) |
|
|
metabolic processing (485) |
|
|
reaction (624) |
|
|
response to substance (623) |
|
|
activity (2549) |
|
|
cleavage (22) |
|
|
degradation (120) |
|
|
expression (2187) |
|
|
localization (74) |
|
|
phosphorylation (590) |
|
|
reaction (3393) |
|
|
response to substance (713) |
|
|
ubiquitination (21) |
|
|
abundance (630) |
|
|
acetylation (96) |
|
|
activity (2865) |
|
|
cleavage (666) |
|
|
degradation (347) |
|
|
expression (3238) |
|
|
localization (244) |
|
|
phosphorylation (1060) |
|
|
reaction (1574) |
|
|
response to substance (641) |
|
|
secretion (901) |
|
|
stability (138) |
|
|
ubiquitination (61) |
|
|
uptake (378) |
|
 |
4. Semantic Terms |
 |
 |
|
4. Semantic Terms |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmacologic Substance [STY:T121] (11019) |
|
|
Organic Chemical [STY:T109] (44144) |
|
 |
A. Anatomy |
 |
 |
|
A. Anatomy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
|
|
|
|
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
|
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
|
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
|
|
|
|
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Craniosynostosis radial aplasia syndrome [MESH:C536788] (30) |
|
|
Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia [MESH:C565328] (23) |
|
|
Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia [MESH:C565328] (23) |
|
|
Wolcott-Rallison syndrome [MESH:C536739] (92) |
|
|
|
|
|
|
|
|
|
|
|
Mandibuloacral dysplasia with type A lipodystrophy [MESH:C535705] (490) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
|
|
|
|
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Meckel Syndrome, Type 4 [MESH:C567003] (20) |
|
|
|
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allanson Pantzar McLeod syndrome [MESH:C537048] (503) |
|
|
|
|
|
|
|
|
|
|
|
Aortic Valve, Calcification of [MESH:C562942] (655) |
|
|
|
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
|
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chromosome 17 deletion [MESH:C538045] (769) |
|
|
|
|
|
|
|
|
Mandibuloacral dysplasia with type A lipodystrophy [MESH:C535705] (490) |
|
 |
C01. Bacterial Infections and Mycoses |
 |
 |
|
C01. Bacterial Infections and Mycoses |
|
|
|
|
|
Helicobacter Infections [MESH:D016481] (579) |
|
|
Chlamydia Infections [MESH:D002690] (1696) |
|
|
Mycoplasma Infections [MESH:D009175] (1947) |
|
|
Meningococcal Infections [MESH:D008589] (242) |
|
|
Listeriosis [MESH:D008088] (1622) |
|
|
|
|
|
Leprosy [MESH:D007918] (261) |
|
|
Mycobacterium Infections, Nontuberculous [MESH:D009165] (480) |
|
|
Tuberculosis, Pulmonary [MESH:D014397] (678) |
|
|
Chlamydia Infections [MESH:D002690] (1693) |
|
|
|
|
|
Hidradenitis suppurativa, familial [MESH:C538118] (67) |
|
|
Arthritis, Infectious [MESH:D001170] (1702) |
|
|
Respiratory Tract Infections [MESH:D012141] (199) |
|
|
Appendicitis [MESH:D001064] (774) |
|
|
Peritonitis [MESH:D010538] (800) |
|
|
|
|
|
AIDS-related Kaposi sarcoma [MESH:C554498] (914) |
|
|
Shock, Septic [MESH:D012772] (1830) |
|
|
Endotoxemia [MESH:D019446] (1289) |
|
|
|
|
|
Chlamydia Infections [MESH:D002690] (1693) |
|
|
|
|
|
|
|
|
Candidiasis familial chronic mucocutaneous, autosomal recessive [MESH:C537979] (36) |
|
|
|
|
|
Hidradenitis suppurativa, familial [MESH:C538118] (67) |
|
|
|
|
|
Hidradenitis suppurativa, familial [MESH:C538118] (67) |
|
|
Endotoxemia [MESH:D019446] (1289) |
|
|
|
|
|
|
|
|
Candidiasis familial chronic mucocutaneous, autosomal recessive [MESH:C537979] (36) |
|
|
|
|
|
Candidiasis familial chronic mucocutaneous, autosomal recessive [MESH:C537979] (36) |
|
 |
C02. Virus Diseases |
 |
 |
|
C02. Virus Diseases |
|
|
Pneumonia, Viral [MESH:D011024] (125) |
|
|
Viremia [MESH:D014766] (41) |
|
|
|
|
|
|
|
|
Encephalitis, Herpes Simplex [MESH:D020803] (72) |
|
|
Meningitis, Aseptic [MESH:D008582] (1305) |
|
|
|
|
|
|
|
|
Hepatitis B, Chronic [MESH:D019694] (277) |
|
|
Encephalitis, Herpes Simplex [MESH:D020803] (72) |
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
AIDS-related Kaposi sarcoma [MESH:C554498] (914) |
|
|
|
|
|
WHIM syndrome [MESH:C536697] (148) |
|
|
Encephalitis, Herpes Simplex [MESH:D020803] (72) |
|
|
|
|
|
Hepatitis B, Chronic [MESH:D019694] (277) |
|
|
Hepatitis C, Chronic [MESH:D019698] (142) |
|
|
Meningitis, Aseptic [MESH:D008582] (1305) |
|
|
|
|
|
AIDS-related Kaposi sarcoma [MESH:C554498] (914) |
|
|
|
|
|
Flavivirus Infections [MESH:D018177] (159) |
|
|
Hepatitis C, Chronic [MESH:D019698] (142) |
|
|
|
|
|
|
|
|
Respiratory Syncytial Virus Infections [MESH:D018357] (852) |
|
|
|
|
|
|
|
|
Severe Acute Respiratory Syndrome [MESH:D045169] (127) |
|
|
Influenza, Human [MESH:D007251] (1075) |
|
|
Cardiovirus Infections [MESH:D018188] (1548) |
|
|
Coxsackievirus Infections [MESH:D003384] (194) |
|
|
|
|
|
|
|
|
Acquired Immunodeficiency Syndrome [MESH:D000163] (743) |
|
|
HIV-Associated Lipodystrophy Syndrome [MESH:D039682] (91) |
|
|
HIV Wasting Syndrome [MESH:D019247] (1956) |
|
|
AIDS-related Kaposi sarcoma [MESH:C554498] (914) |
|
|
|
|
|
|
|
|
Acquired Immunodeficiency Syndrome [MESH:D000163] (743) |
|
|
HIV-Associated Lipodystrophy Syndrome [MESH:D039682] (91) |
|
|
HIV Wasting Syndrome [MESH:D019247] (1956) |
|
|
|
|
|
WHIM syndrome [MESH:C536697] (148) |
|
|
Acquired Immunodeficiency Syndrome [MESH:D000163] (743) |
|
|
Papillomavirus Infections [MESH:D030361] (537) |
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
WHIM syndrome [MESH:C536697] (148) |
|
 |
C03. Parasitic Diseases |
 |
 |
|
C03. Parasitic Diseases |
|
|
Liver Diseases, Parasitic [MESH:D008109] (1009) |
|
|
|
|
|
AIDS-related Kaposi sarcoma [MESH:C554498] (914) |
|
|
|
|
|
Entamoebiasis [MESH:D004749] (1689) |
|
|
|
|
|
Leishmaniasis, Cutaneous [MESH:D016773] (2359) |
|
|
Leishmaniasis, Visceral [MESH:D007898] (2149) |
|
|
Malaria, Falciparum [MESH:D016778] (438) |
|
|
|
|
|
Leishmaniasis, Cutaneous [MESH:D016773] (2359) |
|
 |
C04. Neoplasms |
 |
 |
|
C04. Neoplasms |
|
|
Hamartoma [MESH:D006222] (1484) |
|
|
Neoplasms, Radiation-Induced [MESH:D009381] (174) |
|
|
|
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
|
|
|
Leukemia, Plasma Cell [MESH:D007952] (11) |
|
|
|
|
|
Leukemia, Lymphocytic, Chronic, B-Cell [MESH:D015451] (2562) |
|
|
Leukemia, Prolymphocytic, T-Cell [MESH:D015461] (2) |
|
|
Leukemia-Lymphoma, Adult T-Cell [MESH:D015459] (138) |
|
|
Leukemia, Prolymphocytic, T-Cell [MESH:D015461] (2) |
|
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma [MESH:D015452] (354) |
|
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma [MESH:D054218] (510) |
|
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive [MESH:D015464] (1032) |
|
|
Leukemia, Myelomonocytic, Juvenile [MESH:D054429] (344) |
|
|
Leukemia, Megakaryoblastic, Acute [MESH:D007947] (279) |
|
|
Leukemia, Promyelocytic, Acute [MESH:D015473] (1367) |
|
|
Hodgkin Disease [MESH:D006689] (1082) |
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
Lymphoma, Follicular [MESH:D008224] (1025) |
|
|
Lymphoma, Large-Cell, Anaplastic [MESH:D017728] (420) |
|
|
Lymphoma, Mantle-Cell [MESH:D020522] (561) |
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
Lymphoma, AIDS-Related [MESH:D016483] (278) |
|
|
Lymphoma, Large B-Cell, Diffuse [MESH:D016403] (2012) |
|
|
Lymphoma, Primary Effusion [MESH:D054685] (2) |
|
|
Lymphoma, Extranodal NK-T-Cell [MESH:D054391] (132) |
|
|
Lymphoma, Large-Cell, Anaplastic [MESH:D017728] (420) |
|
|
Lymphoma, T-Cell, Cutaneous [MESH:D016410] (912) |
|
|
Hepatoblastoma [MESH:D018197] (548) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
|
|
|
|
|
|
Liposarcoma, Myxoid [MESH:D018208] (358) |
|
|
Sarcoma, Synovial [MESH:D013584] (993) |
|
|
|
|
|
Metachondromatosis [MESH:C562938] (49) |
|
|
Chondrosarcoma, Mesenchymal [MESH:D018211] (1161) |
|
|
Carney-Stratakis Syndrome [MESH:C564650] (65) |
|
|
Mastocytosis, Systemic [MESH:D034721] (769) |
|
|
Osteosarcoma [MESH:D012516] (2175) |
|
|
|
|
|
|
|
|
Metachondromatosis [MESH:C562938] (49) |
|
|
Solitary Fibrous Tumors [MESH:D054364] (79) |
|
|
Fibromatosis, Aggressive [MESH:D018222] (1562) |
|
|
Leiomyoma [MESH:D007889] (744) |
|
|
Leiomyosarcoma [MESH:D007890] (977) |
|
|
Smooth Muscle Tumor [MESH:D018235] (132) |
|
|
|
|
|
Rhabdomyosarcoma, Alveolar [MESH:D018232] (149) |
|
|
Rhabdomyosarcoma, Embryonal [MESH:D018233] (98) |
|
|
Hemangiosarcoma [MESH:D006394] (1836) |
|
|
Leiomyosarcoma [MESH:D007890] (977) |
|
|
Osteosarcoma [MESH:D012516] (2175) |
|
|
Sarcoma, Experimental [MESH:D012513] (128) |
|
|
Sarcoma, Synovial [MESH:D013584] (993) |
|
|
Chondrosarcoma, Mesenchymal [MESH:D018211] (1161) |
|
|
Liposarcoma, Myxoid [MESH:D018208] (358) |
|
|
|
|
|
Rhabdomyosarcoma, Alveolar [MESH:D018232] (149) |
|
|
Rhabdomyosarcoma, Embryonal [MESH:D018233] (98) |
|
|
AIDS-related Kaposi sarcoma [MESH:C554498] (914) |
|
|
Testicular Germ Cell Tumor [MESH:C563236] (176) |
|
|
|
|
|
Retinoblastoma [MESH:D012175] (319) |
|
|
Gliosarcoma [MESH:D018316] (880) |
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Melanoma astrocytoma syndrome [MESH:C536149] (159) |
|
|
Glioblastoma [MESH:D005909] (2554) |
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Neuroblastoma [MESH:D009447] (1420) |
|
|
|
|
|
Melanoma astrocytoma syndrome [MESH:C536149] (159) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Carney-Stratakis Syndrome [MESH:C564650] (65) |
|
|
|
|
|
Adenoma, Liver Cell [MESH:D018248] (685) |
|
|
Mesothelioma [MESH:D008654] (2567) |
|
|
Oncocytoma, renal [MESH:C537750] (35) |
|
|
|
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
Pancreatic cancer, adult [MESH:C535836] (572) |
|
|
Thyroid cancer, papillary [MESH:C536915] (111) |
|
|
Carcinoma, Basal Cell [MESH:D002280] (1628) |
|
|
Carcinoma, Small Cell [MESH:D018288] (1317) |
|
|
Carcinoma, Transitional Cell [MESH:D002295] (2662) |
|
|
Adenocarcinoma of lung [MESH:C538231] (1487) |
|
|
Adenocarcinoma Of Esophagus [MESH:C562730] (1530) |
|
|
Adenocarcinoma, Clear Cell [MESH:D018262] (1291) |
|
|
Carcinoma, Adenoid Cystic [MESH:D003528] (1561) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Carcinoma, Intraductal, Noninfiltrating [MESH:D002285] (500) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Cholangiocarcinoma [MESH:D018281] (2398) |
|
|
Adrenocortical Carcinoma, Hereditary [MESH:C565972] (769) |
|
|
Carcinoma, Ductal, Breast [MESH:D018270] (1112) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
Cervical Intraepithelial Neoplasia [MESH:D018290] (56) |
|
|
Prostatic Intraepithelial Neoplasia [MESH:D019048] (1565) |
|
|
Carcinoma, squamous cell of head and neck [MESH:C535575] (1543) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Bowen's Disease [MESH:D001913] (247) |
|
|
Carcinoma, Basal Cell [MESH:D002280] (1628) |
|
|
Pilomatrixoma [MESH:D018296] (252) |
|
|
Carcinoma, Intraductal, Noninfiltrating [MESH:D002285] (500) |
|
|
Carcinoma, Ductal, Breast [MESH:D018270] (1112) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
Mesothelioma [MESH:D008654] (2567) |
|
|
Retinoblastoma [MESH:D012175] (319) |
|
|
Gliosarcoma [MESH:D018316] (880) |
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Melanoma astrocytoma syndrome [MESH:C536149] (159) |
|
|
Glioblastoma [MESH:D005909] (2554) |
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Neuroblastoma [MESH:D009447] (1420) |
|
|
Papilloma [MESH:D010212] (2243) |
|
|
Carcinoma, squamous cell of head and neck [MESH:C535575] (1543) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Bowen's Disease [MESH:D001913] (247) |
|
|
Nerve Sheath Neoplasms [MESH:D018317] (365) |
|
|
Meningioma, familial [MESH:C537443] (195) |
|
|
|
|
|
Retinoblastoma [MESH:D012175] (319) |
|
|
Gliosarcoma [MESH:D018316] (880) |
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Melanoma astrocytoma syndrome [MESH:C536149] (159) |
|
|
Glioblastoma [MESH:D005909] (2554) |
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Neuroblastoma [MESH:D009447] (1420) |
|
|
|
|
|
Melanoma astrocytoma syndrome [MESH:C536149] (159) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Carney-Stratakis Syndrome [MESH:C564650] (65) |
|
|
Plasmacytoma [MESH:D010954] (7) |
|
|
Waldenstrom Macroglobulinemia [MESH:D008258] (11) |
|
|
Leukemia, Plasma Cell [MESH:D007952] (11) |
|
|
Angiokeratoma [MESH:D000794] (54) |
|
|
Hemangiosarcoma [MESH:D006394] (1836) |
|
|
|
|
|
Hemangioendothelioma, Epithelioid [MESH:D018323] (34) |
|
|
Hemangioma, capillary infantile [MESH:C535860] (190) |
|
|
Hemangioblastoma [MESH:D018325] (395) |
|
|
Hemangioma, Cavernous, Central Nervous System [MESH:D020786] (35) |
|
|
Meningioma, familial [MESH:C537443] (195) |
|
|
AIDS-related Kaposi sarcoma [MESH:C554498] (914) |
|
|
|
|
|
Melanoma astrocytoma syndrome [MESH:C536149] (159) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Skin Neoplasms [MESH:D012878] (2992) |
|
|
Soft Tissue Neoplasms [MESH:D012983] (2003) |
|
|
Metachondromatosis [MESH:C562938] (49) |
|
|
Carcinoma, Ductal, Breast [MESH:D018270] (1112) |
|
|
Hereditary Breast and Ovarian Cancer Syndrome [MESH:D061325] (143) |
|
|
|
|
|
Gallbladder Neoplasms [MESH:D005706] (993) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Adenocarcinoma Of Esophagus [MESH:C562730] (1530) |
|
|
Cecal Neoplasms [MESH:D002430] (822) |
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
Colorectal Neoplasms, Hereditary Nonpolyposis [MESH:D003123] (258) |
|
|
Rectal Neoplasms [MESH:D012004] (717) |
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
|
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
Adenoma, Liver Cell [MESH:D018248] (685) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
Pancreatic cancer, adult [MESH:C535836] (572) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
Pituitary Neoplasms [MESH:D010911] (981) |
|
|
|
|
|
|
|
|
Adrenocortical Carcinoma, Hereditary [MESH:C565972] (769) |
|
|
Multiple Endocrine Neoplasia, Type IV [MESH:C567059] (297) |
|
|
Hereditary Breast and Ovarian Cancer Syndrome [MESH:D061325] (143) |
|
|
Pancreatic cancer, adult [MESH:C535836] (572) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
Testicular Germ Cell Tumor [MESH:C563236] (176) |
|
|
Thyroid cancer, anaplastic [MESH:C536910] (489) |
|
|
Thyroid cancer, papillary [MESH:C536915] (111) |
|
|
|
|
|
Retinoblastoma [MESH:D012175] (319) |
|
|
Carcinoma, squamous cell of head and neck [MESH:C535575] (1543) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Adenocarcinoma Of Esophagus [MESH:C562730] (1530) |
|
|
Leukoplakia, Oral [MESH:D007972] (921) |
|
|
Salivary Gland Neoplasms [MESH:D012468] (968) |
|
|
Tongue Neoplasms [MESH:D014062] (1518) |
|
|
|
|
|
|
|
|
Nasopharyngeal carcinoma [MESH:C538339] (1198) |
|
|
Thyroid cancer, anaplastic [MESH:C536910] (489) |
|
|
Thyroid cancer, papillary [MESH:C536915] (111) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
|
Melanoma astrocytoma syndrome [MESH:C536149] (159) |
|
|
|
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
|
|
|
Papilloma, Choroid Plexus [MESH:D020288] (769) |
|
|
|
|
|
Pituitary Neoplasms [MESH:D010911] (914) |
|
|
|
|
|
Meningioma, familial [MESH:C537443] (195) |
|
|
Thymus Neoplasms [MESH:D013953] (247) |
|
|
|
|
|
Adenocarcinoma of lung [MESH:C538231] (1487) |
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
|
Small Cell Lung Carcinoma [MESH:D055752] (1380) |
|
|
|
|
|
Vaginal Neoplasms [MESH:D014625] (363) |
|
|
Endometrial Neoplasms [MESH:D016889] (1987) |
|
|
Uterine Cervical Neoplasms [MESH:D002583] (978) |
|
|
Penile Neoplasms [MESH:D010412] (890) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Testicular Germ Cell Tumor [MESH:C563236] (176) |
|
|
Ureteral Neoplasms [MESH:D014516] (574) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
Oncocytoma, renal [MESH:C537750] (35) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
|
Sarcoma, Experimental [MESH:D012513] (128) |
|
|
|
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
|
|
|
Multiple Endocrine Neoplasia, Type IV [MESH:C567059] (297) |
|
|
Anaplasia [MESH:D000708] (348) |
|
|
Neoplasm Invasiveness [MESH:D009361] (3388) |
|
|
Neoplasm Recurrence, Local [MESH:D009364] (1949) |
|
|
Neoplasm, Residual [MESH:D018365] (478) |
|
|
Cell Transformation, Neoplastic [MESH:D002471] (3389) |
|
|
Lymphatic Metastasis [MESH:D008207] (917) |
|
|
Hemangioma, capillary infantile [MESH:C535860] (190) |
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
Meningioma, familial [MESH:C537443] (195) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Birt-Hogg-Dube Syndrome [MESH:D058249] (35) |
|
|
Colorectal Neoplasms, Hereditary Nonpolyposis [MESH:D003123] (260) |
|
|
Hereditary Breast and Ovarian Cancer Syndrome [MESH:D061325] (143) |
|
|
Li-Fraumeni Syndrome [MESH:D016864] (859) |
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
Metachondromatosis [MESH:C562938] (49) |
|
|
Multiple Endocrine Neoplasia, Type IV [MESH:C567059] (297) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Aberrant Crypt Foci [MESH:D058739] (326) |
|
|
Leukoplakia, Oral [MESH:D007972] (921) |
|
|
Xeroderma Pigmentosum, Complementation Group B [MESH:C562590] (31) |
|
|
Xeroderma Pigmentosum, Complementation Group D [MESH:C562591] (48) |
|
|
Xeroderma Pigmentosum, Complementation Group F [MESH:C562592] (38) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
|
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
WHIM syndrome [MESH:C536697] (148) |
|
 |
C05. Musculoskeletal Diseases |
 |
 |
|
C05. Musculoskeletal Diseases |
|
|
Cartilage Diseases [MESH:D002357] (438) |
|
|
|
|
|
Marfan Syndrome [MESH:D008382] (646) |
|
|
Mandibuloacral dysplasia with type A lipodystrophy [MESH:C535705] (490) |
|
|
Hajdu-Cheney Syndrome [MESH:D031845] (42) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Laron Syndrome [MESH:D046150] (91) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
Short Stature, Idiopathic, Autosomal [MESH:C565805] (194) |
|
|
|
|
|
Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia [MESH:C565328] (23) |
|
|
Craniosynostosis radial aplasia syndrome [MESH:C536788] (30) |
|
|
Wolcott-Rallison syndrome [MESH:C536739] (92) |
|
|
Metaphyseal Anadysplasia 2 [MESH:C567771] (452) |
|
|
Cleidocranial Dysplasia [MESH:D002973] (129) |
|
|
Enchondromatosis [MESH:D004687] (170) |
|
|
Langer-Giedion Syndrome [MESH:D015826] (25) |
|
|
|
|
|
|
|
|
Metachondromatosis [MESH:C562938] (49) |
|
|
|
|
|
Short Stature, Idiopathic, Autosomal [MESH:C565805] (194) |
|
|
|
|
|
Osteoporosis, Postmenopausal [MESH:D015663] (2351) |
|
|
Metachondromatosis [MESH:C562938] (49) |
|
|
|
|
|
|
|
|
Mandibuloacral dysplasia with type A lipodystrophy [MESH:C535705] (490) |
|
|
Hajdu-Cheney Syndrome [MESH:D031845] (42) |
|
|
|
|
|
|
|
|
Metachondromatosis [MESH:C562938] (49) |
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
|
|
|
Intervertebral disc disease [MESH:C535531] (514) |
|
|
Intervertebral disc disease [MESH:C535531] (514) |
|
|
Kyphosis [MESH:D007738] (637) |
|
|
|
|
|
|
|
|
Arthritis, Psoriatic [MESH:D015535] (1859) |
|
|
Spondylitis, Ankylosing [MESH:D013167] (431) |
|
|
|
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
Clubfoot [MESH:D003025] (79) |
|
|
|
|
|
Heart-hand syndrome, Slovenian type [MESH:C535852] (77) |
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
|
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
Calcification of Joints and Arteries [MESH:C565891] (60) |
|
|
Spondylitis, Ankylosing [MESH:D013167] (431) |
|
|
Arthritis, Experimental [MESH:D001169] (3142) |
|
|
Arthritis, Infectious [MESH:D001170] (1702) |
|
|
Arthritis, Juvenile [MESH:D001171] (1060) |
|
|
Arthritis, Psoriatic [MESH:D015535] (1859) |
|
|
Arthritis, Rheumatoid [MESH:D001172] (3603) |
|
|
Osteoarthritis [MESH:D010003] (1743) |
|
|
|
|
|
Arthritis, Psoriatic [MESH:D015535] (1859) |
|
|
Spondylitis, Ankylosing [MESH:D013167] (431) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
Tight skin contracture syndrome, lethal [MESH:C536920] (84) |
|
|
Alpha-B Crystallinopathy [MESH:C563848] (135) |
|
|
Muscle Weakness [MESH:D018908] (478) |
|
|
Myopathies, Structural, Congenital [MESH:D020914] (272) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
Tight skin contracture syndrome, lethal [MESH:C536920] (84) |
|
|
|
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
Hyperexplexia hereditary [MESH:C538136] (80) |
|
|
|
|
|
Muscular Dystrophy, Congenital, Lmna-Related [MESH:C567708] (77) |
|
|
Muscular Dystrophy, Duchenne [MESH:D020388] (942) |
|
|
Muscular Dystrophy, Emery-Dreifuss [MESH:D020389] (169) |
|
|
Muscular Dystrophy, Facioscapulohumeral [MESH:D020391] (854) |
|
|
Limb-girdle muscular dystrophy, type 1B [MESH:C535898] (77) |
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
Dermatomyositis [MESH:D003882] (1826) |
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
Dermatomyositis [MESH:D003882] (1826) |
|
|
|
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
LIG4 Syndrome [MESH:C564694] (24) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
Cleidocranial Dysplasia [MESH:D002973] (129) |
|
|
Costello Syndrome [MESH:D056685] (407) |
|
|
Holoprosencephaly [MESH:D016142] (218) |
|
|
Microcephaly [MESH:D008831] (700) |
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
Craniosynostosis radial aplasia syndrome [MESH:C536788] (30) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
|
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
|
|
|
Craniosynostosis radial aplasia syndrome [MESH:C536788] (30) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Chondrodysplasia, acromesomelic, with genital anomalies [MESH:C537913] (20) |
|
|
Metaphyseal Anadysplasia 2 [MESH:C567771] (452) |
|
|
Brachydactyly type A2 [MESH:C537089] (28) |
|
|
|
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
Clubfoot [MESH:D003025] (79) |
|
|
Meckel Syndrome, Type 4 [MESH:C567003] (20) |
|
|
|
|
|
Heart-hand syndrome, Slovenian type [MESH:C535852] (77) |
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia [MESH:C565328] (23) |
|
|
Craniosynostosis radial aplasia syndrome [MESH:C536788] (30) |
|
|
Arthritis, Juvenile [MESH:D001171] (1060) |
|
|
Arthritis, Rheumatoid [MESH:D001172] (3603) |
|
|
Osteoarthritis [MESH:D010003] (1743) |
|
 |
C06. Digestive System Diseases |
 |
 |
|
C06. Digestive System Diseases |
|
|
|
|
|
|
|
|
Cholangitis [MESH:D002761] (203) |
|
|
|
|
|
Intrahepatic Cholestasis of Pregnancy [MESH:C535932] (101) |
|
|
Cholestasis, progressive familial intrahepatic 1 [MESH:C535933] (263) |
|
|
Cholestasis, progressive familial intrahepatic 3 [MESH:C535935] (101) |
|
|
Alagille Syndrome [MESH:D016738] (105) |
|
|
Liver Cirrhosis, Biliary [MESH:D008105] (1274) |
|
|
Gallbladder Neoplasms [MESH:D005706] (993) |
|
|
Gallbladder Neoplasms [MESH:D005706] (993) |
|
|
Barrett Esophagus [MESH:D001471] (1930) |
|
|
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease [MESH:C563789] (17) |
|
|
Waardenburg Syndrome, Type 4c [MESH:C567679] (17) |
|
|
|
|
|
Gallbladder Neoplasms [MESH:D005706] (993) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Adenocarcinoma Of Esophagus [MESH:C562730] (1530) |
|
|
Carney-Stratakis Syndrome [MESH:C564650] (65) |
|
|
Cecal Neoplasms [MESH:D002430] (822) |
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
Colorectal Neoplasms, Hereditary Nonpolyposis [MESH:D003123] (258) |
|
|
Rectal Neoplasms [MESH:D012004] (717) |
|
|
|
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
Adenoma, Liver Cell [MESH:D018248] (685) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
Pancreatic cancer, adult [MESH:C535836] (572) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
|
|
|
Barrett Esophagus [MESH:D001471] (1930) |
|
|
Esophageal Stenosis [MESH:D004940] (490) |
|
|
|
|
|
Gastroesophageal Reflux [MESH:D005764] (1465) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Adenocarcinoma Of Esophagus [MESH:C562730] (1530) |
|
|
Esophagitis, Peptic [MESH:D004942] (709) |
|
|
Appendicitis [MESH:D001064] (774) |
|
|
Mucositis [MESH:D052016] (1238) |
|
|
Colitis, Ulcerative [MESH:D003093] (2601) |
|
|
Enterocolitis, Necrotizing [MESH:D020345] (1367) |
|
|
Esophagitis, Peptic [MESH:D004942] (709) |
|
|
Colitis, Ulcerative [MESH:D003093] (2601) |
|
|
Crohn Disease [MESH:D003424] (2585) |
|
|
Peptic Ulcer Hemorrhage [MESH:D010438] (553) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Esophageal Squamous Cell Carcinoma [MESH:C562729] (2396) |
|
|
Adenocarcinoma Of Esophagus [MESH:C562730] (1530) |
|
|
Carney-Stratakis Syndrome [MESH:C564650] (65) |
|
|
Cecal Neoplasms [MESH:D002430] (822) |
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
Colorectal Neoplasms, Hereditary Nonpolyposis [MESH:D003123] (258) |
|
|
Rectal Neoplasms [MESH:D012004] (717) |
|
|
|
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
Intestinal Perforation [MESH:D007416] (471) |
|
|
Appendicitis [MESH:D001064] (774) |
|
|
Cecal Neoplasms [MESH:D002430] (822) |
|
|
|
|
|
Colitis, Ulcerative [MESH:D003093] (2601) |
|
|
Irritable Bowel Syndrome [MESH:D043183] (429) |
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
Colorectal Neoplasms, Hereditary Nonpolyposis [MESH:D003123] (258) |
|
|
|
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
|
|
|
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease [MESH:C563789] (17) |
|
|
Waardenburg Syndrome, Type 4c [MESH:C567679] (17) |
|
|
|
|
|
Duodenal Ulcer [MESH:D004381] (1549) |
|
|
Enterocolitis, Necrotizing [MESH:D020345] (1367) |
|
|
Colitis, Ulcerative [MESH:D003093] (2601) |
|
|
Crohn Disease [MESH:D003424] (2585) |
|
|
Cecal Neoplasms [MESH:D002430] (822) |
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
Colorectal Neoplasms, Hereditary Nonpolyposis [MESH:D003123] (258) |
|
|
Rectal Neoplasms [MESH:D012004] (717) |
|
|
|
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
|
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
Celiac Disease [MESH:D002446] (340) |
|
|
|
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
Rectal Neoplasms [MESH:D012004] (717) |
|
|
Duodenal Ulcer [MESH:D004381] (1549) |
|
|
Esophagitis, Peptic [MESH:D004942] (709) |
|
|
Stomach Ulcer [MESH:D013276] (2915) |
|
|
Gastroparesis [MESH:D018589] (732) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Stomach Ulcer [MESH:D013276] (2915) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Hepatomegaly [MESH:D006529] (1169) |
|
|
Hepatorenal Syndrome [MESH:D006530] (910) |
|
|
Hypertension, Portal [MESH:D006975] (869) |
|
|
Liver Diseases, Parasitic [MESH:D008109] (1009) |
|
|
Intrahepatic Cholestasis of Pregnancy [MESH:C535932] (101) |
|
|
Cholestasis, progressive familial intrahepatic 1 [MESH:C535933] (263) |
|
|
Cholestasis, progressive familial intrahepatic 3 [MESH:C535935] (101) |
|
|
Alagille Syndrome [MESH:D016738] (105) |
|
|
Liver Cirrhosis, Biliary [MESH:D008105] (1274) |
|
|
Non-alcoholic Fatty Liver Disease [MESH:C541083] (1567) |
|
|
|
|
|
End Stage Liver Disease [MESH:D058625] (108) |
|
|
Hepatic Encephalopathy [MESH:D006501] (1795) |
|
|
Massive Hepatic Necrosis [MESH:D047508] (93) |
|
|
Hepatitis, Alcoholic [MESH:D006519] (1613) |
|
|
Hepatitis, Autoimmune [MESH:D019693] (1982) |
|
|
Hepatitis B, Chronic [MESH:D019694] (277) |
|
|
Hepatitis C, Chronic [MESH:D019698] (142) |
|
|
|
|
|
Hepatitis B, Chronic [MESH:D019694] (277) |
|
|
Hepatitis C, Chronic [MESH:D019698] (142) |
|
|
Liver Cirrhosis, Alcoholic [MESH:D008104] (3066) |
|
|
Liver Cirrhosis, Biliary [MESH:D008105] (1274) |
|
|
Liver Cirrhosis, Experimental [MESH:D008106] (4589) |
|
|
Hepatitis, Alcoholic [MESH:D006519] (1613) |
|
|
Liver Cirrhosis, Alcoholic [MESH:D008104] (3066) |
|
|
Adenoma, Liver Cell [MESH:D018248] (685) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
|
|
|
Pancreatic cancer, adult [MESH:C535836] (572) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
Pancreatitis, Chronic [MESH:D050500] (276) |
|
|
Peritonitis [MESH:D010538] (800) |
|
 |
C07. Stomatognathic Diseases |
 |
 |
|
C07. Stomatognathic Diseases |
|
|
|
|
|
|
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
Behcet Syndrome [MESH:D001528] (1784) |
|
|
Mucositis [MESH:D052016] (1238) |
|
|
Oral Submucous Fibrosis [MESH:D009914] (2432) |
|
|
Oral Ulcer [MESH:D019226] (488) |
|
|
Stomatitis [MESH:D013280] (1235) |
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Leukoplakia, Oral [MESH:D007972] (921) |
|
|
Salivary Gland Neoplasms [MESH:D012468] (968) |
|
|
Tongue Neoplasms [MESH:D014062] (1518) |
|
|
Periodontitis [MESH:D010518] (843) |
|
|
Salivary Gland Neoplasms [MESH:D012468] (968) |
|
|
Tongue Neoplasms [MESH:D014062] (1518) |
|
|
|
|
|
|
|
|
Nasopharyngeal carcinoma [MESH:C538339] (1198) |
|
|
|
|
|
Nasopharyngeal carcinoma [MESH:C538339] (1198) |
|
|
Tooth Abnormalities [MESH:D014071] (622) |
|
|
|
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Tooth Abnormalities [MESH:D014071] (622) |
|
 |
C08. Respiratory Tract Diseases |
 |
 |
|
C08. Respiratory Tract Diseases |
|
|
Not Fully Specified [NFS] (1984) |
|
|
Granuloma, Respiratory Tract [MESH:D015769] (502) |
|
|
Bronchial Hyperreactivity [MESH:D016535] (1357) |
|
|
Bronchiectasis [MESH:D001987] (1792) |
|
|
Asthma, Aspirin-Induced [MESH:D055963] (1055) |
|
|
Bronchitis, Chronic [MESH:D029481] (569) |
|
|
Hypertension, Pulmonary [MESH:D006976] (2000) |
|
|
Pulmonary Edema [MESH:D011654] (2109) |
|
|
Pulmonary Embolism [MESH:D011655] (1118) |
|
|
Pulmonary Fibrosis [MESH:D011658] (3140) |
|
|
Respiratory Distress Syndrome, Adult [MESH:D012128] (864) |
|
|
Tuberculosis, Pulmonary [MESH:D014397] (678) |
|
|
Alveolitis, Extrinsic Allergic [MESH:D000542] (496) |
|
|
Anthracosis [MESH:D055008] (1805) |
|
|
Berylliosis [MESH:D001607] (2005) |
|
|
Silicosis [MESH:D012829] (1273) |
|
|
Asthma [MESH:D001249] (3903) |
|
|
Bronchitis, Chronic [MESH:D029481] (569) |
|
|
Bronchitis, Chronic [MESH:D029481] (569) |
|
|
Pulmonary Emphysema [MESH:D011656] (1259) |
|
|
Acute Lung Injury [MESH:D055371] (1907) |
|
|
Anthracosis [MESH:D055008] (1805) |
|
|
Berylliosis [MESH:D001607] (2005) |
|
|
Silicosis [MESH:D012829] (1273) |
|
|
Adenocarcinoma of lung [MESH:C538231] (1487) |
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
|
Small Cell Lung Carcinoma [MESH:D055752] (1380) |
|
|
Pneumonia, Viral [MESH:D011024] (125) |
|
|
Pleurisy [MESH:D010998] (2070) |
|
|
Pneumothorax, Primary Spontaneous [MESH:C566795] (35) |
|
|
Cough [MESH:D003371] (179) |
|
|
Respiratory Distress Syndrome, Adult [MESH:D012128] (864) |
|
|
Respiratory Insufficiency [MESH:D012131] (841) |
|
|
Pitt-Hopkins syndrome [MESH:C537403] (113) |
|
|
Ige Responsiveness, Atopic [MESH:C564133] (267) |
|
|
Alveolitis, Extrinsic Allergic [MESH:D000542] (495) |
|
|
Asthma, Aspirin-Induced [MESH:D055963] (1055) |
|
|
Influenza, Human [MESH:D007251] (1075) |
|
|
Pleurisy [MESH:D010998] (2070) |
|
|
Severe Acute Respiratory Syndrome [MESH:D045169] (127) |
|
|
Tuberculosis, Pulmonary [MESH:D014397] (678) |
|
|
Bronchitis, Chronic [MESH:D029481] (569) |
|
|
Pneumonia, Viral [MESH:D011024] (125) |
|
|
|
|
|
Adenocarcinoma of lung [MESH:C538231] (1487) |
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
|
Small Cell Lung Carcinoma [MESH:D055752] (1380) |
|
 |
C09. Otorhinolaryngologic Diseases |
 |
 |
|
C09. Otorhinolaryngologic Diseases |
|
|
|
|
|
|
|
|
Tinnitus [MESH:D014012] (109) |
|
|
Hearing Loss, Bilateral [MESH:D006312] (55) |
|
|
Hearing Loss, Sudden [MESH:D003639] (56) |
|
|
Yemenite deaf-blind hypopigmentation syndrome [MESH:C536771] (17) |
|
|
Charcot-Marie-Tooth disease, Type 2J [MESH:C535417] (22) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
Vestibular Diseases [MESH:D015837] (819) |
|
|
|
|
|
|
|
|
Nasopharyngeal carcinoma [MESH:C538339] (1198) |
|
|
|
|
|
|
|
|
Nasopharyngeal carcinoma [MESH:C538339] (1198) |
|
|
|
|
|
Nasopharyngeal carcinoma [MESH:C538339] (1198) |
|
 |
C10. Nervous System Diseases |
 |
 |
|
C10. Nervous System Diseases |
|
|
Not Fully Specified [NFS] (4027) |
|
|
Chronobiology Disorders [MESH:D021081] (970) |
|
|
Myasthenia Gravis [MESH:D009157] (632) |
|
|
Uveomeningoencephalitic Syndrome [MESH:D014607] (39) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
Encephalomyelitis, Autoimmune, Experimental [MESH:D004681] (806) |
|
|
dopamine beta hydroxylase deficiency [MESH:C535600] (63) |
|
|
|
|
|
Hypotension, Orthostatic [MESH:D007024] (679) |
|
|
Endocrine-Cerebroosteodysplasia [MESH:C567210] (26) |
|
|
Brain Edema [MESH:D001929] (1165) |
|
|
Brain Injuries [MESH:D001930] (3429) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Supranuclear Palsy, Progressive [MESH:D013494] (235) |
|
|
Huntington Disease-Like 1 [MESH:C566398] (98) |
|
|
|
|
|
Parkinson Disease 4, Autosomal Dominant Lewy Body [MESH:C565324] (136) |
|
|
Parkinson Disease 6, Autosomal Recessive Early-Onset [MESH:C565276] (42) |
|
|
Parkinson Disease 4, Autosomal Dominant Lewy Body [MESH:C565324] (136) |
|
|
|
|
|
Cerebral Palsy, Spastic Quadriplegic, 1 [MESH:C567853] (99) |
|
|
Hepatic Encephalopathy [MESH:D006501] (1795) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
|
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Gaucher Disease, Atypical, Due To Saposin C Deficiency [MESH:C566435] (56) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
|
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
|
|
|
Papilloma, Choroid Plexus [MESH:D020288] (769) |
|
|
|
|
|
Pituitary Neoplasms [MESH:D010911] (914) |
|
|
Joubert syndrome 5 [MESH:C537688] (20) |
|
|
|
|
|
Ataxia Telangiectasia [MESH:D001260] (142) |
|
|
Intracranial Arteriovenous Malformations [MESH:D002538] (1015) |
|
|
Ischemic Attack, Transient [MESH:D002546] (1313) |
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Carotid Artery Thrombosis [MESH:D002341] (138) |
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
|
|
|
Sinus Thrombosis, Intracranial [MESH:D012851] (356) |
|
|
Cerebral Hemorrhage [MESH:D002543] (2873) |
|
|
Subarachnoid Hemorrhage [MESH:D013345] (1082) |
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Creutzfeldt-Jakob Syndrome [MESH:D007562] (118) |
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
|
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
Pick Disease of the Brain [MESH:D020774] (184) |
|
|
Huntington Disease-Like 1 [MESH:C566398] (98) |
|
|
Parkinson Disease 4, Autosomal Dominant Lewy Body [MESH:C565324] (136) |
|
|
Seizures [MESH:D012640] (4502) |
|
|
Status Epilepticus [MESH:D013226] (4014) |
|
|
Epilepsy, Temporal Lobe [MESH:D004833] (1108) |
|
|
Epilepsy, Tonic-Clonic [MESH:D004830] (1042) |
|
|
Epileptic encephalopathy, Lennox-Gastaut type [MESH:C535500] (70) |
|
|
|
|
|
Migraine Disorders [MESH:D008881] (2318) |
|
|
Bardet-Biedl Syndrome [MESH:D020788] (110) |
|
|
Pituitary Neoplasms [MESH:D010911] (914) |
|
|
Pituitary Neoplasms [MESH:D010911] (981) |
|
|
Hyperprolactinemia [MESH:D006966] (603) |
|
|
|
|
|
Short Stature, Idiopathic, Autosomal [MESH:C565805] (194) |
|
|
|
|
|
Encephalomyelitis, Autoimmune, Experimental [MESH:D004681] (806) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
Neurodegeneration Due To Cerebral Folate Transport Deficiency [MESH:C567791] (53) |
|
|
|
|
|
|
|
|
|
|
|
Encephalitis, Herpes Simplex [MESH:D020803] (72) |
|
|
Meningitis, Aseptic [MESH:D008582] (1305) |
|
|
|
|
|
Encephalitis, Herpes Simplex [MESH:D020803] (72) |
|
|
Meningitis, Aseptic [MESH:D008582] (1305) |
|
|
Meningitis, Aseptic [MESH:D008582] (1305) |
|
|
Uveomeningoencephalitic Syndrome [MESH:D014607] (39) |
|
|
Spongiform Encephalopathy with Neuropsychiatric Features [MESH:C564678] (98) |
|
|
Creutzfeldt-Jakob Syndrome [MESH:D007562] (118) |
|
|
Gerstmann-Straussler-Scheinker Disease [MESH:D016098] (98) |
|
|
Insomnia, Fatal Familial [MESH:D034062] (98) |
|
|
Scrapie [MESH:D012608] (462) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Supranuclear Palsy, Progressive [MESH:D013494] (235) |
|
|
Dyskinesia, Drug-Induced [MESH:D004409] (1389) |
|
|
|
|
|
Huntington Disease-Like 1 [MESH:C566398] (98) |
|
|
Dystonia 12 [MESH:C538001] (36) |
|
|
|
|
|
Parkinson Disease 4, Autosomal Dominant Lewy Body [MESH:C565324] (136) |
|
|
Parkinson Disease 6, Autosomal Recessive Early-Onset [MESH:C565276] (42) |
|
|
Parkinson Disease 4, Autosomal Dominant Lewy Body [MESH:C565324] (136) |
|
|
Joubert syndrome 5 [MESH:C537688] (20) |
|
|
Spinal Cord Compression [MESH:D013117] (1800) |
|
|
Spinal Cord Injuries [MESH:D013119] (1674) |
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
Neuronopathy, Distal Hereditary Motor, Type IIB [MESH:C567084] (219) |
|
|
|
|
|
Joubert syndrome 5 [MESH:C537688] (20) |
|
|
Supranuclear Palsy, Progressive [MESH:D013494] (235) |
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
Optic Neuropathy, Ischemic [MESH:D018917] (50) |
|
|
|
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
|
|
|
Encephalomyelitis, Autoimmune, Experimental [MESH:D004681] (806) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
|
|
|
Holoprosencephaly [MESH:D016142] (218) |
|
|
Hemangioma, Cavernous, Central Nervous System [MESH:D020786] (35) |
|
|
Intracranial Arteriovenous Malformations [MESH:D002538] (1015) |
|
|
|
|
|
Charcot-Marie-Tooth disease, Type 4E [MESH:C535301] (121) |
|
|
Charcot-Marie-Tooth disease, Type 2F [MESH:C535413] (219) |
|
|
Charcot-Marie-Tooth disease, Type 2I [MESH:C535416] (22) |
|
|
Charcot-Marie-Tooth disease, Type 2J [MESH:C535417] (22) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Charcot-Marie-Tooth disease, Type 1D [MESH:C537985] (108) |
|
|
Charcot-Marie-Tooth disease, Type 2B1 [MESH:C537990] (77) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate D [MESH:C564333] (22) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate B [MESH:C564703] (27) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Microcephaly [MESH:D008831] (700) |
|
|
Classical Lissencephalies and Subcortical Band Heterotopias [MESH:D054221] (114) |
|
|
Classical Lissencephalies and Subcortical Band Heterotopias [MESH:D054221] (114) |
|
|
Meningomyelocele [MESH:D008591] (100) |
|
|
Spinal Dysraphism [MESH:D016135] (1025) |
|
|
Neural tube defect, folate-sensitive [MESH:C536409] (111) |
|
|
Meckel Syndrome, Type 4 [MESH:C567003] (20) |
|
|
Melanoma astrocytoma syndrome [MESH:C536149] (159) |
|
|
|
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
|
|
|
Papilloma, Choroid Plexus [MESH:D020288] (769) |
|
|
|
|
|
Pituitary Neoplasms [MESH:D010911] (914) |
|
|
|
|
|
Meningioma, familial [MESH:C537443] (195) |
|
|
Nerve Sheath Neoplasms [MESH:D018317] (286) |
|
|
Ataxia Telangiectasia [MESH:D001260] (142) |
|
|
von Hippel-Lindau Disease [MESH:D006623] (580) |
|
|
|
|
|
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease [MESH:C563789] (17) |
|
|
Spongiform Encephalopathy with Neuropsychiatric Features [MESH:C564678] (98) |
|
|
Gerstmann-Straussler-Scheinker Disease [MESH:D016098] (98) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Rett Syndrome [MESH:D015518] (143) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
|
|
|
Charcot-Marie-Tooth disease, Type 4E [MESH:C535301] (121) |
|
|
Charcot-Marie-Tooth disease, Type 2F [MESH:C535413] (219) |
|
|
Charcot-Marie-Tooth disease, Type 2I [MESH:C535416] (22) |
|
|
Charcot-Marie-Tooth disease, Type 2J [MESH:C535417] (22) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Charcot-Marie-Tooth disease, Type 1D [MESH:C537985] (108) |
|
|
Charcot-Marie-Tooth disease, Type 2B1 [MESH:C537990] (77) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate D [MESH:C564333] (22) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate B [MESH:C564703] (27) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Huntington Disease-Like 1 [MESH:C566398] (98) |
|
|
Ceroid lipofuscinosis, neuronal 1, infantile [MESH:C537948] (946) |
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
Ceroid Lipofuscinosis, Neuronal, 6 [MESH:C566627] (20) |
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
Parkinson Disease 4, Autosomal Dominant Lewy Body [MESH:C565324] (136) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
Neuronopathy, Distal Hereditary Motor, Type IIB [MESH:C567084] (219) |
|
|
Parkinson Disease 6, Autosomal Recessive Early-Onset [MESH:C565276] (42) |
|
|
Parkinson Disease 4, Autosomal Dominant Lewy Body [MESH:C565324] (136) |
|
|
Spongiform Encephalopathy with Neuropsychiatric Features [MESH:C564678] (98) |
|
|
Gerstmann-Straussler-Scheinker Disease [MESH:D016098] (98) |
|
|
Insomnia, Fatal Familial [MESH:D034062] (98) |
|
|
Scrapie [MESH:D012608] (462) |
|
|
Supranuclear Palsy, Progressive [MESH:D013494] (235) |
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
|
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
Meningism [MESH:D008580] (43) |
|
|
Neurogenic Inflammation [MESH:D020078] (2246) |
|
|
Seizures [MESH:D012640] (4514) |
|
|
Dystonia [MESH:D004421] (848) |
|
|
Hyperkinesis [MESH:D006948] (1799) |
|
|
Ataxia with vitamin E deficiency [MESH:C535393] (271) |
|
|
Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25) |
|
|
|
|
|
Ataxia Telangiectasia [MESH:D001260] (142) |
|
|
Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25) |
|
|
|
|
|
Learning Disorders [MESH:D007859] (2727) |
|
|
Language Development Disorders [MESH:D007805] (351) |
|
|
Aphasia [MESH:D001037] (219) |
|
|
|
|
|
Coma [MESH:D003128] (524) |
|
|
Amnesia [MESH:D000647] (1911) |
|
|
Epileptic encephalopathy, Lennox-Gastaut type [MESH:C535500] (70) |
|
|
Pitt-Hopkins syndrome [MESH:C537403] (113) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
De Lange Syndrome [MESH:D003635] (55) |
|
|
Down Syndrome [MESH:D004314] (1287) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Mental Retardation, X-Linked, Syndromic, Jarid1c-Related [MESH:C564494] (6) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Rett Syndrome [MESH:D015518] (143) |
|
|
Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25) |
|
|
|
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
Muscle Weakness [MESH:D018908] (478) |
|
|
Muscular Atrophy [MESH:D009133] (1234) |
|
|
|
|
|
Hyperexplexia hereditary [MESH:C538136] (80) |
|
|
Joubert syndrome 5 [MESH:C537688] (20) |
|
|
Headache [MESH:D006261] (1416) |
|
|
Pain, Intractable [MESH:D010148] (707) |
|
|
Neuralgia, Postherpetic [MESH:D051474] (742) |
|
|
|
|
|
Alternating hemiplegia of childhood [MESH:C536589] (70) |
|
|
Supranuclear Palsy, Progressive [MESH:D013494] (235) |
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
|
|
|
|
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
Taste Disorders [MESH:D013651] (461) |
|
|
Tinnitus [MESH:D014012] (109) |
|
|
Hearing Loss, Bilateral [MESH:D006312] (55) |
|
|
Hearing Loss, Sudden [MESH:D003639] (56) |
|
|
Yemenite deaf-blind hypopigmentation syndrome [MESH:C536771] (17) |
|
|
Charcot-Marie-Tooth disease, Type 2J [MESH:C535417] (22) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
Hyperalgesia [MESH:D006930] (3929) |
|
|
Hypesthesia [MESH:D006987] (58) |
|
|
Paresthesia [MESH:D010292] (416) |
|
|
|
|
|
Yemenite deaf-blind hypopigmentation syndrome [MESH:C536771] (17) |
|
|
|
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
Neuronopathy, Distal Hereditary Motor, Type IIB [MESH:C567084] (219) |
|
|
Neuronopathy, Distal Hereditary Motor, Type IIB [MESH:C567084] (219) |
|
|
Alpha-B Crystallinopathy [MESH:C563848] (135) |
|
|
Myopathies, Structural, Congenital [MESH:D020914] (272) |
|
|
|
|
|
Muscular Dystrophy, Congenital, Lmna-Related [MESH:C567708] (77) |
|
|
Muscular Dystrophy, Duchenne [MESH:D020388] (942) |
|
|
Muscular Dystrophy, Emery-Dreifuss [MESH:D020389] (169) |
|
|
Muscular Dystrophy, Facioscapulohumeral [MESH:D020391] (854) |
|
|
Limb-girdle muscular dystrophy, type 1B [MESH:C535898] (77) |
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
|
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
Dermatomyositis [MESH:D003882] (1826) |
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
Dermatomyositis [MESH:D003882] (1826) |
|
|
Myasthenia Gravis [MESH:D009157] (632) |
|
|
Congenital myasthenic syndrome ib [MESH:C536089] (46) |
|
|
Diabetic Neuropathies [MESH:D003929] (2442) |
|
|
Neuralgia, Postherpetic [MESH:D051474] (742) |
|
|
Nerve Sheath Neoplasms [MESH:D018317] (286) |
|
|
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease [MESH:C563789] (17) |
|
|
|
|
|
Charcot-Marie-Tooth disease, Type 4E [MESH:C535301] (121) |
|
|
Charcot-Marie-Tooth disease, Type 2F [MESH:C535413] (219) |
|
|
Charcot-Marie-Tooth disease, Type 2I [MESH:C535416] (22) |
|
|
Charcot-Marie-Tooth disease, Type 2J [MESH:C535417] (22) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Charcot-Marie-Tooth disease, Type 1D [MESH:C537985] (108) |
|
|
Charcot-Marie-Tooth disease, Type 2B1 [MESH:C537990] (77) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate D [MESH:C564333] (22) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate B [MESH:C564703] (27) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Dyskinesia, Drug-Induced [MESH:D004409] (1389) |
|
|
Arsenic Poisoning [MESH:D020261] (2540) |
|
|
Manganese Poisoning [MESH:D020149] (2214) |
|
|
|
|
|
|
|
|
|
|
|
Insomnia, Fatal Familial [MESH:D034062] (98) |
|
|
Spinal Cord Injuries [MESH:D013119] (1676) |
|
|
Brain Injuries [MESH:D001930] (3431) |
|
 |
C11. Eye Diseases |
 |
 |
|
C11. Eye Diseases |
|
|
Eyelid Diseases [MESH:D005141] (882) |
|
|
Pterygium [MESH:D011625] (44) |
|
|
Corneal Neovascularization [MESH:D016510] (622) |
|
|
|
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Retinitis Pigmentosa [MESH:D012174] (414) |
|
|
Graves Ophthalmopathy [MESH:D049970] (165) |
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
Leber Congenital Amaurosis 10 [MESH:C565720] (20) |
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
|
|
|
Retinoblastoma [MESH:D012175] (319) |
|
|
|
|
|
Alpha-B Crystallinopathy [MESH:C563848] (135) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
|
|
|
Glaucoma, Open-Angle [MESH:D005902] (1281) |
|
|
Joubert syndrome 5 [MESH:C537688] (20) |
|
|
Supranuclear Palsy, Progressive [MESH:D013494] (235) |
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
Optic Neuropathy, Ischemic [MESH:D018917] (50) |
|
|
|
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
|
|
|
|
|
|
Graves Ophthalmopathy [MESH:D049970] (165) |
|
|
Diabetic Retinopathy [MESH:D003930] (1371) |
|
|
Retinal Detachment [MESH:D012163] (1639) |
|
|
Retinal Vein Occlusion [MESH:D012170] (607) |
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
Leber Congenital Amaurosis 10 [MESH:C565720] (20) |
|
|
|
|
|
Macular Degeneration, Age-Related, 3 [MESH:C563838] (35) |
|
|
Macular Degeneration, Age-Related, 10 [MESH:C566935] (162) |
|
|
Macular Edema [MESH:D008269] (557) |
|
|
Retinitis Pigmentosa [MESH:D012174] (1307) |
|
|
Retinoblastoma [MESH:D012175] (319) |
|
|
|
|
|
Choroidal Neovascularization [MESH:D020256] (550) |
|
|
|
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Uveomeningoencephalitic Syndrome [MESH:D014607] (39) |
|
|
|
|
|
Behcet Syndrome [MESH:D001528] (1784) |
|
|
|
|
|
Yemenite deaf-blind hypopigmentation syndrome [MESH:C536771] (17) |
|
 |
C12. Male Urogenital Diseases |
 |
 |
|
C12. Male Urogenital Diseases |
|
|
|
|
|
|
|
|
Penile Neoplasms [MESH:D010412] (890) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Testicular Germ Cell Tumor [MESH:C563236] (176) |
|
|
|
|
|
Aromatase deficiency [MESH:C537436] (277) |
|
|
Azoospermia [MESH:D053713] (1052) |
|
|
Oligospermia [MESH:D009845] (799) |
|
|
Penile Neoplasms [MESH:D010412] (890) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
Prostatic Hyperplasia [MESH:D011470] (336) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Prostatitis [MESH:D011472] (424) |
|
|
Erectile Dysfunction [MESH:D007172] (1791) |
|
|
|
|
|
Chlamydia Infections [MESH:D002690] (1693) |
|
|
Cryptorchidism [MESH:D003456] (215) |
|
|
Allanson Pantzar McLeod syndrome [MESH:C537048] (503) |
|
|
Cryptorchidism [MESH:D003456] (215) |
|
|
|
|
|
Cortisone reductase deficiency [MESH:C536447] (136) |
|
|
Aromatase deficiency [MESH:C537436] (277) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
Frasier Syndrome [MESH:D052159] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Meacham Winn Culler syndrome [MESH:C538162] (57) |
|
|
Sexual Infantilism [MESH:D050035] (277) |
|
|
Meacham Winn Culler syndrome [MESH:C538162] (57) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
|
|
|
Penile Neoplasms [MESH:D010412] (890) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Testicular Germ Cell Tumor [MESH:C563236] (176) |
|
|
Ureteral Neoplasms [MESH:D014516] (574) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
Oncocytoma, renal [MESH:C537750] (35) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
|
|
|
Joubert syndrome 5 [MESH:C537688] (20) |
|
|
Diabetic Nephropathies [MESH:D003928] (2301) |
|
|
Hepatorenal Syndrome [MESH:D006530] (910) |
|
|
Hydronephrosis [MESH:D006869] (956) |
|
|
Hyperoxaluria [MESH:D006959] (1498) |
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
Meckel Syndrome, Type 4 [MESH:C567003] (20) |
|
|
Medullary cystic kidney disease 1 [MESH:C536137] (61) |
|
|
Oncocytoma, renal [MESH:C537750] (35) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
|
|
|
Glomerulonephritis, IGA [MESH:D005922] (897) |
|
|
Glomerulosclerosis, Focal Segmental [MESH:D005923] (1754) |
|
|
Lupus Nephritis [MESH:D008181] (602) |
|
|
Balkan Nephropathy [MESH:D001449] (772) |
|
|
Kidney Calculi [MESH:D007669] (455) |
|
|
Nephrotic Syndrome [MESH:D009404] (1536) |
|
|
|
|
|
Kidney Tubular Necrosis, Acute [MESH:D007683] (974) |
|
|
|
|
|
Frasier Syndrome [MESH:D052159] (57) |
|
|
Hypomagnesemia 4, Renal [MESH:C567127] (225) |
|
|
Pseudohypoaldosteronism [MESH:D011546] (232) |
|
|
|
|
|
Atypical hemolytic uremic syndrome [MESH:C538266] (277) |
|
|
Ureteral Neoplasms [MESH:D014516] (574) |
|
|
|
|
|
Urinary Bladder Neck Obstruction [MESH:D001748] (924) |
|
|
Urinary Bladder Neck Obstruction [MESH:D001748] (924) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
Urinary Bladder, Overactive [MESH:D053201] (530) |
|
|
Urinary Retention [MESH:D016055] (411) |
|
|
Albuminuria [MESH:D000419] (2394) |
|
|
|
|
|
Kidney Calculi [MESH:D007669] (455) |
|
|
Kidney Calculi [MESH:D007669] (455) |
|
 |
C13. Female Urogenital Diseases and Pregnancy Complications |
 |
 |
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
Not Fully Specified [NFS] (1116) |
|
|
|
|
|
Endometriosis [MESH:D004715] (2461) |
|
|
|
|
|
Chondrodysplasia, acromesomelic, with genital anomalies [MESH:C537913] (20) |
|
|
Primary Ovarian Insufficiency [MESH:D016649] (270) |
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
Hereditary Breast and Ovarian Cancer Syndrome [MESH:D061325] (143) |
|
|
Infertility, Female [MESH:D007247] (2184) |
|
|
|
|
|
Chlamydia Infections [MESH:D002690] (1693) |
|
|
|
|
|
Uterine Cervical Neoplasms [MESH:D002583] (978) |
|
|
Endometrial Neoplasms [MESH:D016889] (1984) |
|
|
Uterine Cervical Neoplasms [MESH:D002583] (978) |
|
|
Vaginal Neoplasms [MESH:D014625] (363) |
|
|
Vulvar Lichen Sclerosus [MESH:D007724] (825) |
|
|
Allanson Pantzar McLeod syndrome [MESH:C537048] (503) |
|
|
|
|
|
Cortisone reductase deficiency [MESH:C536447] (136) |
|
|
Aromatase deficiency [MESH:C537436] (277) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
Frasier Syndrome [MESH:D052159] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Meacham Winn Culler syndrome [MESH:C538162] (57) |
|
|
Sexual Infantilism [MESH:D050035] (277) |
|
|
Meacham Winn Culler syndrome [MESH:C538162] (57) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
|
|
|
Vaginal Neoplasms [MESH:D014625] (363) |
|
|
Hereditary Breast and Ovarian Cancer Syndrome [MESH:D061325] (143) |
|
|
Endometrial Neoplasms [MESH:D016889] (1989) |
|
|
Uterine Cervical Neoplasms [MESH:D002583] (978) |
|
|
Ureteral Neoplasms [MESH:D014516] (574) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
Oncocytoma, renal [MESH:C537750] (35) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
|
|
|
Joubert syndrome 5 [MESH:C537688] (20) |
|
|
Diabetic Nephropathies [MESH:D003928] (2301) |
|
|
Hepatorenal Syndrome [MESH:D006530] (910) |
|
|
Hydronephrosis [MESH:D006869] (956) |
|
|
Hyperoxaluria [MESH:D006959] (1498) |
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
Meckel Syndrome, Type 4 [MESH:C567003] (20) |
|
|
Medullary cystic kidney disease 1 [MESH:C536137] (61) |
|
|
Oncocytoma, renal [MESH:C537750] (35) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
|
|
|
Glomerulonephritis, IGA [MESH:D005922] (897) |
|
|
Glomerulosclerosis, Focal Segmental [MESH:D005923] (1754) |
|
|
Lupus Nephritis [MESH:D008181] (602) |
|
|
Balkan Nephropathy [MESH:D001449] (772) |
|
|
Kidney Calculi [MESH:D007669] (455) |
|
|
Nephrotic Syndrome [MESH:D009404] (1536) |
|
|
|
|
|
Kidney Tubular Necrosis, Acute [MESH:D007683] (974) |
|
|
|
|
|
Frasier Syndrome [MESH:D052159] (57) |
|
|
Hypomagnesemia 4, Renal [MESH:C567127] (225) |
|
|
Pseudohypoaldosteronism [MESH:D011546] (232) |
|
|
|
|
|
Atypical hemolytic uremic syndrome [MESH:C538266] (277) |
|
|
Ureteral Neoplasms [MESH:D014516] (574) |
|
|
|
|
|
Urinary Bladder Neck Obstruction [MESH:D001748] (924) |
|
|
Urinary Bladder Neck Obstruction [MESH:D001748] (924) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
Urinary Bladder, Overactive [MESH:D053201] (530) |
|
|
Urinary Retention [MESH:D016055] (411) |
|
|
Albuminuria [MESH:D000419] (2394) |
|
|
|
|
|
Kidney Calculi [MESH:D007669] (455) |
|
|
Kidney Calculi [MESH:D007669] (455) |
|
|
Intrahepatic Cholestasis of Pregnancy [MESH:C535932] (101) |
|
|
Diabetes, Gestational [MESH:D016640] (1157) |
|
|
Placenta Diseases [MESH:D010922] (1781) |
|
|
Pregnancy Complications, Cardiovascular [MESH:D011249] (1994) |
|
|
Embryo Loss [MESH:D020964] (288) |
|
|
Fetal Growth Retardation [MESH:D005317] (986) |
|
|
Pre-Eclampsia [MESH:D011225] (1435) |
|
|
|
|
|
Premature Birth [MESH:D047928] (118) |
|
|
Prenatal Exposure Delayed Effects [MESH:D011297] (870) |
|
 |
C14. Cardiovascular Diseases |
 |
 |
|
C14. Cardiovascular Diseases |
|
|
Not Fully Specified [NFS] (2667) |
|
|
Pregnancy Complications, Cardiovascular [MESH:D011249] (1994) |
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Heart-hand syndrome, Slovenian type [MESH:C535852] (77) |
|
|
Alagille Syndrome [MESH:D016738] (105) |
|
|
Heterotaxy Syndrome [MESH:D059446] (84) |
|
|
Marfan Syndrome [MESH:D008382] (646) |
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
Heart Septal Defects, Ventricular [MESH:D006345] (160) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
|
|
|
Intracranial Arteriovenous Malformations [MESH:D002538] (1015) |
|
|
Hemangioma, Cavernous, Central Nervous System [MESH:D020786] (35) |
|
|
Intracranial Arteriovenous Malformations [MESH:D002538] (1015) |
|
|
Heart Failure [MESH:D006333] (4058) |
|
|
Pericardial Effusion [MESH:D010490] (1015) |
|
|
Atrial Fibrillation [MESH:D001281] (1053) |
|
|
Bradycardia [MESH:D001919] (1899) |
|
|
Ventricular Fibrillation [MESH:D014693] (624) |
|
|
Sinoatrial Block [MESH:D012848] (95) |
|
|
|
|
|
Torsades de Pointes [MESH:D016171] (880) |
|
|
Hypertrophy, Left Ventricular [MESH:D017379] (1430) |
|
|
Cardiomyopathy, Dilated, 1t [MESH:C566052] (76) |
|
|
Cardiomyopathy, Dilated, 1u [MESH:C566296] (56) |
|
|
Cardiomyopathy, Dilated, 1y [MESH:C567507] (103) |
|
|
Alpha-B Crystallinopathy [MESH:C563848] (135) |
|
|
Diabetic Cardiomyopathies [MESH:D058065] (1995) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Myocarditis [MESH:D009205] (1708) |
|
|
Cardiomyopathy, Dilated, 1t [MESH:C566052] (76) |
|
|
Cardiomyopathy, Dilated, 1u [MESH:C566296] (56) |
|
|
Cardiomyopathy, Dilated, 1y [MESH:C567507] (103) |
|
|
|
|
|
Cardiomyopathy, Familial Hypertrophic, 3 [MESH:C566170] (103) |
|
|
Death, Sudden, Cardiac [MESH:D016757] (168) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Heart-hand syndrome, Slovenian type [MESH:C535852] (77) |
|
|
Heterotaxy Syndrome [MESH:D059446] (84) |
|
|
Marfan Syndrome [MESH:D008382] (646) |
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
Heart Septal Defects, Ventricular [MESH:D006345] (160) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
|
|
|
Aortic Valve, Calcification of [MESH:C562942] (655) |
|
|
Cardiomyopathy, Hypertrophic [MESH:D002312] (1451) |
|
|
|
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Myocardial Stunning [MESH:D017682] (1816) |
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
|
Angina, Unstable [MESH:D000789] (782) |
|
|
Angina, Stable [MESH:D060050] (1702) |
|
|
Microvascular Angina [MESH:D017566] (44) |
|
|
Coronary Artery Disease [MESH:D003324] (2685) |
|
|
Coronary Thrombosis [MESH:D003328] (255) |
|
|
Coronary Restenosis [MESH:D023903] (1683) |
|
|
Myocardial Stunning [MESH:D017682] (1816) |
|
|
Shock, Cardiogenic [MESH:D012770] (269) |
|
|
Ventricular Dysfunction, Left [MESH:D018487] (1631) |
|
|
|
|
|
Aortic Valve, Calcification of [MESH:C562942] (655) |
|
|
Calcification of Joints and Arteries [MESH:C565891] (60) |
|
|
Angioedema [MESH:D000799] (837) |
|
|
Capillary Leak Syndrome [MESH:D019559] (18) |
|
|
Hyperemia [MESH:D006940] (2372) |
|
|
Hypertension [MESH:D006973] (5655) |
|
|
Optic Neuropathy, Ischemic [MESH:D018917] (50) |
|
|
Retinal Vein Occlusion [MESH:D012170] (607) |
|
|
Superior Vena Cava Syndrome [MESH:D013479] (64) |
|
|
Vascular System Injuries [MESH:D057772] (2086) |
|
|
|
|
|
Aortic Rupture [MESH:D001019] (637) |
|
|
Aortic Aneurysm, Abdominal [MESH:D017544] (1519) |
|
|
Aortic Aneurysm, Thoracic [MESH:D017545] (781) |
|
|
Aortic Rupture [MESH:D001019] (637) |
|
|
von Hippel-Lindau Disease [MESH:D006623] (580) |
|
|
|
|
|
Aortic Aneurysm, Abdominal [MESH:D017544] (1519) |
|
|
Aortic Aneurysm, Thoracic [MESH:D017545] (781) |
|
|
Aortic Rupture [MESH:D001019] (637) |
|
|
|
|
|
Atherosclerosis [MESH:D050197] (4188) |
|
|
Coronary Artery Disease [MESH:D003324] (2685) |
|
|
Intracranial Arteriovenous Malformations [MESH:D002538] (1015) |
|
|
|
|
|
Ischemic Attack, Transient [MESH:D002546] (1313) |
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Carotid Artery Thrombosis [MESH:D002341] (138) |
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Intracranial Arteriovenous Malformations [MESH:D002538] (1015) |
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Carotid Artery Thrombosis [MESH:D002341] (138) |
|
|
Sinus Thrombosis, Intracranial [MESH:D012851] (356) |
|
|
Cerebral Hemorrhage [MESH:D002543] (2873) |
|
|
Subarachnoid Hemorrhage [MESH:D013345] (1082) |
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Diabetic Retinopathy [MESH:D003930] (1371) |
|
|
|
|
|
Pulmonary Embolism [MESH:D011655] (1118) |
|
|
|
|
|
Carotid Artery Thrombosis [MESH:D002341] (138) |
|
|
Sinus Thrombosis, Intracranial [MESH:D012851] (356) |
|
|
Coronary Thrombosis [MESH:D003328] (255) |
|
|
|
|
|
Carotid Artery Thrombosis [MESH:D002341] (138) |
|
|
Sinus Thrombosis, Intracranial [MESH:D012851] (356) |
|
|
Retinal Vein Occlusion [MESH:D012170] (607) |
|
|
Multiple Myeloma [MESH:D009101] (2765) |
|
|
Pseudoxanthoma Elasticum [MESH:D011561] (115) |
|
|
Waldenstrom Macroglobulinemia [MESH:D008258] (11) |
|
|
Hemangioma, Cavernous, Central Nervous System [MESH:D020786] (35) |
|
|
Hypotension, Orthostatic [MESH:D007024] (679) |
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Myocardial Stunning [MESH:D017682] (1816) |
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
|
Angina, Unstable [MESH:D000789] (782) |
|
|
Angina, Stable [MESH:D060050] (1702) |
|
|
Microvascular Angina [MESH:D017566] (44) |
|
|
Coronary Artery Disease [MESH:D003324] (2685) |
|
|
Coronary Thrombosis [MESH:D003328] (255) |
|
|
Coronary Restenosis [MESH:D023903] (1683) |
|
|
Myocardial Stunning [MESH:D017682] (1816) |
|
|
No-Reflow Phenomenon [MESH:D054318] (277) |
|
|
Shock, Cardiogenic [MESH:D012770] (269) |
|
|
Raynaud Disease [MESH:D011928] (490) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Ataxia Telangiectasia [MESH:D001260] (142) |
|
|
Behcet Syndrome [MESH:D001528] (1784) |
|
|
Mucocutaneous Lymph Node Syndrome [MESH:D009080] (158) |
|
|
Vasculitis, Leukocytoclastic, Cutaneous [MESH:D018366] (121) |
|
 |
C15. Hemic and Lymphatic Diseases |
 |
 |
|
C15. Hemic and Lymphatic Diseases |
|
|
Not Fully Specified [NFS] (453) |
|
|
Methemoglobinemia [MESH:D008708] (850) |
|
|
Pancytopenia [MESH:D010198] (332) |
|
|
Thrombophilia [MESH:D019851] (592) |
|
|
Anemia, Refractory [MESH:D000753] (1567) |
|
|
Anemia, Sideroblastic [MESH:D000756] (636) |
|
|
|
|
|
Anemia, Diamond-Blackfan [MESH:D029503] (158) |
|
|
Fanconi Anemia, Complementation Group D1 [MESH:C563980] (68) |
|
|
Favism [MESH:D005236] (193) |
|
|
Anemia, Hemolytic, Congenital Nonspherocytic [MESH:D000746] (308) |
|
|
Anemia, Sickle Cell [MESH:D000755] (1722) |
|
|
Favism [MESH:D005236] (193) |
|
|
beta-Thalassemia [MESH:D017086] (458) |
|
|
Bone Marrow failure syndromes [MESH:C536572] (248) |
|
|
Atypical hemolytic uremic syndrome [MESH:C538266] (277) |
|
|
Anemia, Diamond-Blackfan [MESH:D029503] (158) |
|
|
Thrombocythemia, Essential [MESH:D013920] (707) |
|
|
Thrombasthenia [MESH:D013915] (98) |
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
von Willebrand Disease, Type 1 [MESH:D056725] (67) |
|
|
von Willebrand Disease, Type 2 [MESH:D056728] (67) |
|
|
von Willebrand Disease, Type 3 [MESH:D056729] (67) |
|
|
|
|
|
von Willebrand Disease, Type 1 [MESH:D056725] (67) |
|
|
von Willebrand Disease, Type 2 [MESH:D056728] (67) |
|
|
von Willebrand Disease, Type 3 [MESH:D056729] (67) |
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
Thrombasthenia [MESH:D013915] (98) |
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia [MESH:C565328] (23) |
|
|
Thrombocytopenia, Neonatal Alloimmune [MESH:D054098] (79) |
|
|
|
|
|
Atypical hemolytic uremic syndrome [MESH:C538266] (277) |
|
|
Thrombocythemia, Essential [MESH:D013920] (707) |
|
|
Agammaglobulinemia [MESH:D000361] (156) |
|
|
Hypergammaglobulinemia [MESH:D006942] (137) |
|
|
Hypoalbuminemia [MESH:D034141] (1332) |
|
|
Multiple Myeloma [MESH:D009101] (2765) |
|
|
Waldenstrom Macroglobulinemia [MESH:D008258] (11) |
|
|
|
|
|
|
|
|
Anemia, Diamond-Blackfan [MESH:D029503] (158) |
|
|
Fanconi Anemia, Complementation Group D1 [MESH:C563980] (68) |
|
|
Leukemia, Myelomonocytic, Juvenile [MESH:D054429] (344) |
|
|
Anemia, Refractory [MESH:D000753] (1567) |
|
|
Anemia, Sideroblastic [MESH:D000756] (636) |
|
|
Bone Marrow failure syndromes [MESH:C536572] (248) |
|
|
Myeloproliferative Disorder, Chronic, with Eosinophilia [MESH:C565054] (134) |
|
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive [MESH:D015464] (1032) |
|
|
Polycythemia Vera [MESH:D011087] (244) |
|
|
Thrombocythemia, Essential [MESH:D013920] (707) |
|
|
Anemia, Sickle Cell [MESH:D000755] (1722) |
|
|
beta-Thalassemia [MESH:D017086] (458) |
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
Plasminogen Activator Inhibitor-1 Deficiency [MESH:C567640] (328) |
|
|
Thrombasthenia [MESH:D013915] (98) |
|
|
Thrombocythemia, Essential [MESH:D013920] (707) |
|
|
Multiple Myeloma [MESH:D009101] (2765) |
|
|
Pseudoxanthoma Elasticum [MESH:D011561] (115) |
|
|
Waldenstrom Macroglobulinemia [MESH:D008258] (11) |
|
|
Hemangioma, Cavernous, Central Nervous System [MESH:D020786] (35) |
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
von Willebrand Disease, Type 1 [MESH:D056725] (67) |
|
|
von Willebrand Disease, Type 2 [MESH:D056728] (67) |
|
|
von Willebrand Disease, Type 3 [MESH:D056729] (67) |
|
|
Leukostasis [MESH:D018921] (769) |
|
|
Myeloproliferative Disorder, Chronic, with Eosinophilia [MESH:C565054] (134) |
|
|
Lymphocytosis [MESH:D008218] (9) |
|
|
Lymphopenia [MESH:D008231] (990) |
|
|
Neutropenia [MESH:D009503] (1629) |
|
|
|
|
|
Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative [MESH:C565533] (111) |
|
|
Hyper-Ige Recurrent Infection Syndrome, Autosomal Dominant [MESH:C567925] (283) |
|
|
Mucocutaneous Lymph Node Syndrome [MESH:D009080] (158) |
|
|
Thymus Neoplasms [MESH:D013953] (247) |
|
|
|
|
|
|
|
|
Hemophagocytic lymphohistiocytosis, familial, 2 [MESH:C537250] (38) |
|
|
|
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
Agammaglobulinemia [MESH:D000361] (156) |
|
|
Autoimmune Lymphoproliferative Syndrome [MESH:D056735] (704) |
|
|
Giant Lymph Node Hyperplasia [MESH:D005871] (1013) |
|
|
Sarcoidosis [MESH:D012507] (895) |
|
|
Tumor Lysis Syndrome [MESH:D015275] (48) |
|
|
Waldenstrom Macroglobulinemia [MESH:D008258] (11) |
|
|
|
|
|
Leukemia, Lymphocytic, Chronic, B-Cell [MESH:D015451] (2562) |
|
|
Leukemia, Prolymphocytic, T-Cell [MESH:D015461] (2) |
|
|
Leukemia-Lymphoma, Adult T-Cell [MESH:D015459] (138) |
|
|
Leukemia, Prolymphocytic, T-Cell [MESH:D015461] (2) |
|
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma [MESH:D015452] (354) |
|
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma [MESH:D054218] (510) |
|
|
Hodgkin Disease [MESH:D006689] (1082) |
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
Lymphoma, Follicular [MESH:D008224] (1025) |
|
|
Lymphoma, Large-Cell, Anaplastic [MESH:D017728] (420) |
|
|
Lymphoma, Mantle-Cell [MESH:D020522] (561) |
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
Lymphoma, AIDS-Related [MESH:D016483] (278) |
|
|
Lymphoma, Large B-Cell, Diffuse [MESH:D016403] (2012) |
|
|
Lymphoma, Primary Effusion [MESH:D054685] (2) |
|
|
Lymphoma, T-Cell, Cutaneous [MESH:D016410] (912) |
|
|
Heterotaxy Syndrome [MESH:D059446] (84) |
|
|
Hypersplenism [MESH:D006971] (341) |
|
 |
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
 |
 |
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
|
|
|
|
|
Abnormalities, Drug-Induced [MESH:D000014] (1024) |
|
|
Yemenite deaf-blind hypopigmentation syndrome [MESH:C536771] (17) |
|
|
Insulin-Like Growth Factor I, Resistance To [MESH:C564816] (141) |
|
|
Alagille Syndrome [MESH:D016738] (105) |
|
|
Bardet-Biedl Syndrome [MESH:D020788] (110) |
|
|
Costello Syndrome [MESH:D056685] (407) |
|
|
De Lange Syndrome [MESH:D003635] (55) |
|
|
Down Syndrome [MESH:D004314] (1287) |
|
|
Heterotaxy Syndrome [MESH:D059446] (84) |
|
|
Holoprosencephaly [MESH:D016142] (218) |
|
|
Marfan Syndrome [MESH:D008382] (646) |
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
Ectodermal Dysplasia 3, Anhidrotic [MESH:D053359] (10) |
|
|
Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive [MESH:D053360] (10) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Waardenburg syndrome type 2 [MESH:C536463] (55) |
|
|
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease [MESH:C563789] (17) |
|
|
Waardenburg Syndrome, Type 4c [MESH:C567679] (17) |
|
|
|
|
|
Neural tube defect, folate-sensitive [MESH:C536409] (111) |
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Heart-hand syndrome, Slovenian type [MESH:C535852] (77) |
|
|
Alagille Syndrome [MESH:D016738] (105) |
|
|
Heterotaxy Syndrome [MESH:D059446] (84) |
|
|
Marfan Syndrome [MESH:D008382] (646) |
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
Heart Septal Defects, Ventricular [MESH:D006345] (160) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
|
|
|
Intracranial Arteriovenous Malformations [MESH:D002538] (1015) |
|
|
Intracranial Arteriovenous Malformations [MESH:D002538] (1015) |
|
|
De Lange Syndrome [MESH:D003635] (55) |
|
|
Down Syndrome [MESH:D004314] (1287) |
|
|
Holoprosencephaly [MESH:D016142] (218) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
|
|
|
Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25) |
|
|
|
|
|
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease [MESH:C563789] (17) |
|
|
Waardenburg Syndrome, Type 4c [MESH:C567679] (17) |
|
|
|
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
|
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
Hajdu-Cheney Syndrome [MESH:D031845] (42) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
LIG4 Syndrome [MESH:C564694] (24) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
Cleidocranial Dysplasia [MESH:D002973] (129) |
|
|
Holoprosencephaly [MESH:D016142] (218) |
|
|
Microcephaly [MESH:D008831] (700) |
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
Craniosynostosis radial aplasia syndrome [MESH:C536788] (30) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
|
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
|
|
|
Craniosynostosis radial aplasia syndrome [MESH:C536788] (30) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Chondrodysplasia, acromesomelic, with genital anomalies [MESH:C537913] (20) |
|
|
Metaphyseal Anadysplasia 2 [MESH:C567771] (452) |
|
|
Brachydactyly type A2 [MESH:C537089] (28) |
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
Clubfoot [MESH:D003025] (79) |
|
|
Heart-hand syndrome, Slovenian type [MESH:C535852] (77) |
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
Meckel Syndrome, Type 4 [MESH:C567003] (20) |
|
|
Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia [MESH:C565328] (23) |
|
|
Craniosynostosis radial aplasia syndrome [MESH:C536788] (30) |
|
|
Holoprosencephaly [MESH:D016142] (218) |
|
|
Holoprosencephaly [MESH:D016142] (218) |
|
|
Hemangioma, Cavernous, Central Nervous System [MESH:D020786] (35) |
|
|
Intracranial Arteriovenous Malformations [MESH:D002538] (1015) |
|
|
|
|
|
Charcot-Marie-Tooth disease, Type 4E [MESH:C535301] (121) |
|
|
Charcot-Marie-Tooth disease, Type 2F [MESH:C535413] (219) |
|
|
Charcot-Marie-Tooth disease, Type 2I [MESH:C535416] (22) |
|
|
Charcot-Marie-Tooth disease, Type 2J [MESH:C535417] (22) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Charcot-Marie-Tooth disease, Type 1D [MESH:C537985] (108) |
|
|
Charcot-Marie-Tooth disease, Type 2B1 [MESH:C537990] (77) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate D [MESH:C564333] (22) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate B [MESH:C564703] (27) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Microcephaly [MESH:D008831] (700) |
|
|
Classical Lissencephalies and Subcortical Band Heterotopias [MESH:D054221] (114) |
|
|
Classical Lissencephalies and Subcortical Band Heterotopias [MESH:D054221] (114) |
|
|
Meningomyelocele [MESH:D008591] (100) |
|
|
Spinal Dysraphism [MESH:D016135] (1025) |
|
|
Neural tube defect, folate-sensitive [MESH:C536409] (111) |
|
|
Meckel Syndrome, Type 4 [MESH:C567003] (20) |
|
|
Tight skin contracture syndrome, lethal [MESH:C536920] (84) |
|
|
Pseudoxanthoma Elasticum [MESH:D011561] (115) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
Ectodermal Dysplasia 3, Anhidrotic [MESH:D053359] (10) |
|
|
Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive [MESH:D053360] (10) |
|
|
Ichthyosis, X-Linked [MESH:D016114] (91) |
|
|
Hyperkeratosis, Epidermolytic [MESH:D017488] (136) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Xeroderma Pigmentosum, Complementation Group B [MESH:C562590] (31) |
|
|
Xeroderma Pigmentosum, Complementation Group D [MESH:C562591] (48) |
|
|
Xeroderma Pigmentosum, Complementation Group F [MESH:C562592] (38) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
Tooth Abnormalities [MESH:D014071] (622) |
|
|
|
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
|
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Orofacial Cleft 1 [MESH:C566121] (81) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Allanson Pantzar McLeod syndrome [MESH:C537048] (503) |
|
|
Cryptorchidism [MESH:D003456] (215) |
|
|
|
|
|
Cortisone reductase deficiency [MESH:C536447] (136) |
|
|
Aromatase deficiency [MESH:C537436] (277) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
Frasier Syndrome [MESH:D052159] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Meacham Winn Culler syndrome [MESH:C538162] (57) |
|
|
Sexual Infantilism [MESH:D050035] (277) |
|
|
Meacham Winn Culler syndrome [MESH:C538162] (57) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
Fetal Growth Retardation [MESH:D005317] (986) |
|
|
Alagille Syndrome [MESH:D016738] (105) |
|
|
Ataxia Telangiectasia [MESH:D001260] (142) |
|
|
Autoimmune Lymphoproliferative Syndrome [MESH:D056735] (704) |
|
|
Costello Syndrome [MESH:D056685] (407) |
|
|
Frasier Syndrome [MESH:D052159] (57) |
|
|
Hajdu-Cheney Syndrome [MESH:D031845] (42) |
|
|
Marfan Syndrome [MESH:D008382] (646) |
|
|
Werner Syndrome [MESH:D014898] (88) |
|
|
Anemia, Hemolytic, Congenital Nonspherocytic [MESH:D000746] (308) |
|
|
Anemia, Sickle Cell [MESH:D000755] (1722) |
|
|
Favism [MESH:D005236] (193) |
|
|
beta-Thalassemia [MESH:D017086] (458) |
|
|
Anemia, Diamond-Blackfan [MESH:D029503] (158) |
|
|
Fanconi Anemia, Complementation Group D1 [MESH:C563980] (68) |
|
|
Thrombasthenia [MESH:D013915] (98) |
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
von Willebrand Disease, Type 1 [MESH:D056725] (67) |
|
|
von Willebrand Disease, Type 2 [MESH:D056728] (67) |
|
|
von Willebrand Disease, Type 3 [MESH:D056729] (67) |
|
|
Cardiomyopathy, Familial Hypertrophic, 3 [MESH:C566170] (103) |
|
|
De Lange Syndrome [MESH:D003635] (55) |
|
|
Down Syndrome [MESH:D004314] (1287) |
|
|
Holoprosencephaly [MESH:D016142] (218) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
|
|
|
Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Laron Syndrome [MESH:D046150] (91) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
Retinitis Pigmentosa [MESH:D012174] (442) |
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Ichthyosis, X-Linked [MESH:D016114] (91) |
|
|
Muscular Dystrophy, Duchenne [MESH:D020388] (942) |
|
|
Muscular Dystrophy, Emery-Dreifuss [MESH:D020389] (169) |
|
|
Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative [MESH:C565533] (111) |
|
|
Mental Retardation, X-Linked, Syndromic, Jarid1c-Related [MESH:C564494] (6) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Classical Lissencephalies and Subcortical Band Heterotopias [MESH:D054221] (114) |
|
|
Rett Syndrome [MESH:D015518] (143) |
|
|
Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25) |
|
|
Anemia, Sickle Cell [MESH:D000755] (1722) |
|
|
beta-Thalassemia [MESH:D017086] (458) |
|
|
|
|
|
Familial Cold Autoinflammatory Syndrome 2 [MESH:C567090] (11) |
|
|
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease [MESH:C563789] (17) |
|
|
Spongiform Encephalopathy with Neuropsychiatric Features [MESH:C564678] (98) |
|
|
Gerstmann-Straussler-Scheinker Disease [MESH:D016098] (98) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Rett Syndrome [MESH:D015518] (143) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
|
|
|
Charcot-Marie-Tooth disease, Type 4E [MESH:C535301] (121) |
|
|
Charcot-Marie-Tooth disease, Type 2F [MESH:C535413] (219) |
|
|
Charcot-Marie-Tooth disease, Type 2I [MESH:C535416] (22) |
|
|
Charcot-Marie-Tooth disease, Type 2J [MESH:C535417] (22) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Charcot-Marie-Tooth disease, Type 1D [MESH:C537985] (108) |
|
|
Charcot-Marie-Tooth disease, Type 2B1 [MESH:C537990] (77) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate D [MESH:C564333] (22) |
|
|
Charcot-Marie-Tooth Disease, Dominant Intermediate B [MESH:C564703] (27) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Huntington Disease-Like 1 [MESH:C566398] (98) |
|
|
Mental Retardation, X-Linked, Syndromic, Jarid1c-Related [MESH:C564494] (6) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Rett Syndrome [MESH:D015518] (143) |
|
|
Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25) |
|
|
Ceroid lipofuscinosis, neuronal 1, infantile [MESH:C537948] (946) |
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
Ceroid Lipofuscinosis, Neuronal, 6 [MESH:C566627] (20) |
|
|
Senior-Loken Syndrome 6 [MESH:C565708] (20) |
|
|
Trimethylaminuria [MESH:C536561] (61) |
|
|
Aromatase deficiency [MESH:C537436] (277) |
|
|
Coumarin Resistance [MESH:C563039] (397) |
|
|
Drug Metabolism, Poor, CYP2C19-Related [MESH:C563703] (182) |
|
|
Drug Metabolism, Poor, CYP2D6-Related [MESH:C563835] (220) |
|
|
Methylcobalamin Deficiency, CblG Type [MESH:C565394] (49) |
|
|
Hypoproteinemia, Hypercatabolic [MESH:C565476] (99) |
|
|
Progeria [MESH:D011371] (105) |
|
|
succinic semialdehyde dehydrogenase deficiency [MESH:C535803] (42) |
|
|
Alpha-ketoglutarate dehydrogenase deficiency [MESH:C536582] (59) |
|
|
Methylmalonic acidemia [MESH:C537358] (764) |
|
|
Hyperhomocysteinemia [MESH:D020138] (1724) |
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
|
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Gaucher Disease, Atypical, Due To Saposin C Deficiency [MESH:C566435] (56) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
|
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Glucosephosphate Dehydrogenase Deficiency [MESH:D005955] (195) |
|
|
Glycogen Storage Disease IXB [MESH:C563008] (16) |
|
|
Glycogen Storage Disease Type V [MESH:D006012] (165) |
|
|
Mucopolysaccharidosis III [MESH:D009084] (43) |
|
|
Jaundice, Chronic Idiopathic [MESH:D007566] (287) |
|
|
Lipase deficiency combined [MESH:C535904] (16) |
|
|
Hyperlipidemia, Familial Combined [MESH:D006950] (372) |
|
|
Hyperlipoproteinemia Type II [MESH:D006938] (707) |
|
|
|
|
|
Ceroid lipofuscinosis, neuronal 1, infantile [MESH:C537948] (946) |
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
Ceroid Lipofuscinosis, Neuronal, 6 [MESH:C566627] (20) |
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Gaucher Disease, Atypical, Due To Saposin C Deficiency [MESH:C566435] (56) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
|
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
|
|
|
|
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Gaucher Disease, Atypical, Due To Saposin C Deficiency [MESH:C566435] (56) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
|
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
Mucopolysaccharidosis III [MESH:D009084] (43) |
|
|
Molybdenum cofactor deficiency [MESH:C535811] (57) |
|
|
Hemochromatosis [MESH:D006432] (1694) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
Dihydropyrimidine Dehydrogenase Deficiency [MESH:D054067] (88) |
|
|
Hypomagnesemia 4, Renal [MESH:C567127] (225) |
|
|
Pseudohypoaldosteronism [MESH:D011546] (232) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
Cortisone reductase deficiency [MESH:C536447] (136) |
|
|
Ichthyosis, X-Linked [MESH:D016114] (91) |
|
|
Muscular Dystrophy, Congenital, Lmna-Related [MESH:C567708] (77) |
|
|
Muscular Dystrophy, Duchenne [MESH:D020388] (942) |
|
|
Muscular Dystrophy, Emery-Dreifuss [MESH:D020389] (169) |
|
|
Muscular Dystrophy, Facioscapulohumeral [MESH:D020391] (854) |
|
|
Limb-girdle muscular dystrophy, type 1B [MESH:C535898] (77) |
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
Congenital myasthenic syndrome ib [MESH:C536089] (46) |
|
|
Hemangioma, capillary infantile [MESH:C535860] (190) |
|
|
Turcot syndrome [MESH:C536928] (159) |
|
|
Meningioma, familial [MESH:C537443] (195) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Birt-Hogg-Dube Syndrome [MESH:D058249] (35) |
|
|
Colorectal Neoplasms, Hereditary Nonpolyposis [MESH:D003123] (260) |
|
|
Hereditary Breast and Ovarian Cancer Syndrome [MESH:D061325] (143) |
|
|
Li-Fraumeni Syndrome [MESH:D016864] (859) |
|
|
Colorectal Adenomatous Polyposis, Autosomal Recessive [MESH:C563924] (28) |
|
|
Metachondromatosis [MESH:C562938] (49) |
|
|
Multiple Endocrine Neoplasia, Type IV [MESH:C567059] (297) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Ichthyosis, X-Linked [MESH:D016114] (91) |
|
|
Pseudoxanthoma Elasticum [MESH:D011561] (115) |
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
Cutis laxa, recessive [MESH:C536225] (35) |
|
|
Dermatitis, Atopic, 4 [MESH:C565291] (130) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
Ectodermal Dysplasia 3, Anhidrotic [MESH:D053359] (10) |
|
|
Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive [MESH:D053360] (10) |
|
|
Hyperkeratosis, Epidermolytic [MESH:D017488] (136) |
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Xeroderma Pigmentosum, Complementation Group B [MESH:C562590] (31) |
|
|
Xeroderma Pigmentosum, Complementation Group D [MESH:C562591] (48) |
|
|
Xeroderma Pigmentosum, Complementation Group F [MESH:C562592] (38) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
Asphyxia Neonatorum [MESH:D001238] (1648) |
|
|
Infant, Premature, Diseases [MESH:D007235] (1292) |
|
|
Thrombocytopenia, Neonatal Alloimmune [MESH:D054098] (79) |
|
|
|
|
|
Jaundice, Chronic Idiopathic [MESH:D007566] (287) |
|
|
Ichthyosis, X-Linked [MESH:D016114] (91) |
|
|
Hyperkeratosis, Epidermolytic [MESH:D017488] (136) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell -Positive, NK Cell-Negative [MESH:C563440] (79) |
|
|
Bare Lymphocyte Syndrome, Type I [MESH:C565759] (101) |
|
 |
C17. Skin and Connective Tissue Diseases |
 |
 |
|
C17. Skin and Connective Tissue Diseases |
|
|
Cartilage Diseases [MESH:D002357] (438) |
|
|
Dermatomyositis [MESH:D003882] (1826) |
|
|
Marfan Syndrome [MESH:D008382] (646) |
|
|
Pseudoxanthoma Elasticum [MESH:D011561] (115) |
|
|
Scleroderma, Localized [MESH:D012594] (1597) |
|
|
Keloid [MESH:D007627] (1111) |
|
|
Cutis laxa, recessive [MESH:C536225] (35) |
|
|
Lupus Nephritis [MESH:D008181] (602) |
|
|
|
|
|
Mucopolysaccharidosis III [MESH:D009084] (43) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
Arthritis, Juvenile [MESH:D001171] (1060) |
|
|
Arthritis, Rheumatoid [MESH:D001172] (3603) |
|
|
Dermatomyositis [MESH:D003882] (1826) |
|
|
Nephrogenic Fibrosing Dermopathy [MESH:D054989] (452) |
|
|
Pruritus [MESH:D011537] (647) |
|
|
Scleroderma, Localized [MESH:D012594] (1597) |
|
|
Skin Neoplasms [MESH:D012878] (2991) |
|
|
Chloracne [MESH:D054506] (1274) |
|
|
|
|
|
Carcinoma, Ductal, Breast [MESH:D018270] (1112) |
|
|
Hereditary Breast and Ovarian Cancer Syndrome [MESH:D061325] (143) |
|
|
Aromatase deficiency [MESH:C537436] (277) |
|
|
Drug Eruptions [MESH:D003875] (2697) |
|
|
Dermatitis, Atopic, 4 [MESH:C565291] (130) |
|
|
Dermatitis, Allergic Contact [MESH:D017449] (3241) |
|
|
Dermatitis, Occupational [MESH:D009783] (311) |
|
|
|
|
|
Chloracne [MESH:D054506] (1274) |
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
Cortisone reductase deficiency [MESH:C536447] (136) |
|
|
Alopecia [MESH:D000505] (1453) |
|
|
|
|
|
Ichthyosis, X-Linked [MESH:D016114] (91) |
|
|
Hyperkeratosis, Epidermolytic [MESH:D017488] (136) |
|
|
Sunburn [MESH:D013471] (52) |
|
|
Xeroderma Pigmentosum, Complementation Group B [MESH:C562590] (31) |
|
|
Xeroderma Pigmentosum, Complementation Group D [MESH:C562591] (48) |
|
|
Xeroderma Pigmentosum, Complementation Group F [MESH:C562592] (38) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
|
|
|
|
|
|
|
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Yemenite deaf-blind hypopigmentation syndrome [MESH:C536771] (17) |
|
|
Vitiligo [MESH:D014820] (504) |
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
Xeroderma Pigmentosum, Complementation Group B [MESH:C562590] (31) |
|
|
Xeroderma Pigmentosum, Complementation Group D [MESH:C562591] (48) |
|
|
Xeroderma Pigmentosum, Complementation Group F [MESH:C562592] (38) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
Tight skin contracture syndrome, lethal [MESH:C536920] (84) |
|
|
Pseudoxanthoma Elasticum [MESH:D011561] (115) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
Ectodermal Dysplasia 3, Anhidrotic [MESH:D053359] (10) |
|
|
Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive [MESH:D053360] (10) |
|
|
Ichthyosis, X-Linked [MESH:D016114] (91) |
|
|
Hyperkeratosis, Epidermolytic [MESH:D017488] (136) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Xeroderma Pigmentosum, Complementation Group B [MESH:C562590] (31) |
|
|
Xeroderma Pigmentosum, Complementation Group D [MESH:C562591] (48) |
|
|
Xeroderma Pigmentosum, Complementation Group F [MESH:C562592] (38) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
|
|
|
Dermatitis, Atopic, 4 [MESH:C565291] (130) |
|
|
Dermatitis, Allergic Contact [MESH:D017449] (3241) |
|
|
Dermatitis, Occupational [MESH:D009783] (311) |
|
|
Ichthyosis, X-Linked [MESH:D016114] (91) |
|
|
Pseudoxanthoma Elasticum [MESH:D011561] (115) |
|
|
|
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
Cutis laxa, recessive [MESH:C536225] (35) |
|
|
Dermatitis, Atopic, 4 [MESH:C565291] (130) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
Ectodermal Dysplasia 3, Anhidrotic [MESH:D053359] (10) |
|
|
Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive [MESH:D053360] (10) |
|
|
|
|
|
Familial Cold Autoinflammatory Syndrome 2 [MESH:C567090] (11) |
|
|
Hyperkeratosis, Epidermolytic [MESH:D017488] (136) |
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Xeroderma Pigmentosum, Complementation Group B [MESH:C562590] (31) |
|
|
Xeroderma Pigmentosum, Complementation Group D [MESH:C562591] (48) |
|
|
Xeroderma Pigmentosum, Complementation Group F [MESH:C562592] (38) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
|
|
|
|
|
|
Candidiasis familial chronic mucocutaneous, autosomal recessive [MESH:C537979] (36) |
|
|
|
|
|
Hidradenitis suppurativa, familial [MESH:C538118] (67) |
|
|
|
|
|
Leishmaniasis, Cutaneous [MESH:D016773] (2359) |
|
|
|
|
|
WHIM syndrome [MESH:C536697] (148) |
|
|
|
|
|
Mandibuloacral dysplasia with type A lipodystrophy [MESH:C535705] (490) |
|
|
HIV-Associated Lipodystrophy Syndrome [MESH:D039682] (91) |
|
|
Lipodystrophy, Familial Partial [MESH:D052496] (589) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
Lichenoid Eruptions [MESH:D017512] (1324) |
|
|
Arthritis, Psoriatic [MESH:D015535] (1859) |
|
|
Behcet Syndrome [MESH:D001528] (1784) |
|
|
Mucocutaneous Lymph Node Syndrome [MESH:D009080] (158) |
|
|
Angioedema [MESH:D000799] (837) |
|
|
Pemphigoid, Bullous [MESH:D010391] (707) |
|
|
|
|
|
|
|
|
Hidradenitis suppurativa, familial [MESH:C538118] (67) |
|
 |
C18. Nutritional and Metabolic Diseases |
 |
 |
|
C18. Nutritional and Metabolic Diseases |
|
|
Not Fully Specified [NFS] (817) |
|
|
Metabolic Syndrome X [MESH:D024821] (2151) |
|
|
Hepatic Encephalopathy [MESH:D006501] (1795) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
|
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Gaucher Disease, Atypical, Due To Saposin C Deficiency [MESH:C566435] (56) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
|
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Hypercalcemia [MESH:D006934] (1999) |
|
|
Aortic Valve, Calcification of [MESH:C562942] (655) |
|
|
Calcification of Joints and Arteries [MESH:C565891] (60) |
|
|
Ataxia Telangiectasia [MESH:D001260] (142) |
|
|
Colorectal Neoplasms, Hereditary Nonpolyposis [MESH:D003123] (258) |
|
|
Li-Fraumeni Syndrome [MESH:D016864] (859) |
|
|
Werner Syndrome [MESH:D014898] (88) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
Fanconi Anemia, Complementation Group D1 [MESH:C563980] (68) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell -Positive, NK Cell-Negative [MESH:C563440] (79) |
|
|
Bare Lymphocyte Syndrome, Type I [MESH:C565759] (101) |
|
|
Xeroderma Pigmentosum, Complementation Group B [MESH:C562590] (31) |
|
|
Xeroderma Pigmentosum, Complementation Group D [MESH:C562591] (48) |
|
|
Xeroderma Pigmentosum, Complementation Group F [MESH:C562592] (38) |
|
|
XFE Progeroid Syndrome [MESH:C567043] (38) |
|
|
Hyperglycemia [MESH:D006943] (1858) |
|
|
Hypoglycemia [MESH:D007003] (2420) |
|
|
Diabetes Mellitus, Experimental [MESH:D003921] (4771) |
|
|
Diabetes Mellitus, Type 2 [MESH:D003924] (4219) |
|
|
Diabetes, Gestational [MESH:D016640] (1152) |
|
|
Wolcott-Rallison syndrome [MESH:C536739] (92) |
|
|
|
|
|
Metabolic Syndrome X [MESH:D024821] (2151) |
|
|
|
|
|
Hemochromatosis [MESH:D006432] (1694) |
|
|
|
|
|
|
|
|
Hypercholesterolemia [MESH:D006937] (1404) |
|
|
Hyperlipidemia, Familial Combined [MESH:D006950] (372) |
|
|
Hypertriglyceridemia [MESH:D015228] (808) |
|
|
Hyperlipoproteinemia Type II [MESH:D006938] (707) |
|
|
|
|
|
Hypobetalipoproteinemia, Familial, Apolipoprotein B [MESH:D052476] (131) |
|
|
Lipase deficiency combined [MESH:C535904] (16) |
|
|
Mandibuloacral dysplasia with type A lipodystrophy [MESH:C535705] (490) |
|
|
HIV-Associated Lipodystrophy Syndrome [MESH:D039682] (91) |
|
|
Lipodystrophy, Familial Partial [MESH:D052496] (589) |
|
|
|
|
|
Ceroid lipofuscinosis, neuronal 1, infantile [MESH:C537948] (946) |
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
Ceroid Lipofuscinosis, Neuronal, 6 [MESH:C566627] (20) |
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Gaucher Disease, Atypical, Due To Saposin C Deficiency [MESH:C566435] (56) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
|
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
Celiac Disease [MESH:D002446] (340) |
|
|
Hyperhomocysteinemia [MESH:D020138] (1716) |
|
|
Trimethylaminuria [MESH:C536561] (61) |
|
|
Aromatase deficiency [MESH:C537436] (277) |
|
|
Coumarin Resistance [MESH:C563039] (397) |
|
|
Drug Metabolism, Poor, CYP2C19-Related [MESH:C563703] (182) |
|
|
Drug Metabolism, Poor, CYP2D6-Related [MESH:C563835] (220) |
|
|
Methylcobalamin Deficiency, CblG Type [MESH:C565394] (49) |
|
|
Hypoproteinemia, Hypercatabolic [MESH:C565476] (99) |
|
|
Progeria [MESH:D011371] (105) |
|
|
succinic semialdehyde dehydrogenase deficiency [MESH:C535803] (42) |
|
|
Alpha-ketoglutarate dehydrogenase deficiency [MESH:C536582] (59) |
|
|
Methylmalonic acidemia [MESH:C537358] (764) |
|
|
Hyperhomocysteinemia [MESH:D020138] (1724) |
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
|
|
|
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells [MESH:C538539] (74) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
|
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Gaucher Disease, Atypical, Due To Saposin C Deficiency [MESH:C566435] (56) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
|
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
Glucosephosphate Dehydrogenase Deficiency [MESH:D005955] (195) |
|
|
Glycogen Storage Disease IXB [MESH:C563008] (16) |
|
|
Glycogen Storage Disease Type V [MESH:D006012] (165) |
|
|
Mucopolysaccharidosis III [MESH:D009084] (43) |
|
|
Jaundice, Chronic Idiopathic [MESH:D007566] (287) |
|
|
Lipase deficiency combined [MESH:C535904] (16) |
|
|
Hyperlipidemia, Familial Combined [MESH:D006950] (372) |
|
|
Hyperlipoproteinemia Type II [MESH:D006938] (707) |
|
|
|
|
|
Ceroid lipofuscinosis, neuronal 1, infantile [MESH:C537948] (946) |
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
Ceroid Lipofuscinosis, Neuronal, 6 [MESH:C566627] (20) |
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Gaucher Disease, Atypical, Due To Saposin C Deficiency [MESH:C566435] (56) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
|
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
|
|
|
|
|
|
Fabry Disease [MESH:D000795] (56) |
|
|
Gaucher Disease, Atypical, Due To Saposin C Deficiency [MESH:C566435] (56) |
|
|
Krabbe Disease, Atypical, due to Saposin A Deficiency [MESH:C567097] (56) |
|
|
|
|
|
Metachromatic Leukodystrophy due to Saposin B Deficiency [MESH:C562609] (56) |
|
|
Combined Saposin Deficiency [MESH:C567125] (56) |
|
|
Mucopolysaccharidosis III [MESH:D009084] (43) |
|
|
Molybdenum cofactor deficiency [MESH:C535811] (57) |
|
|
Hemochromatosis [MESH:D006432] (1694) |
|
|
Hepatolenticular Degeneration [MESH:D006527] (473) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Neuropathy, hereditary motor and sensory, LOM type [MESH:C535716] (131) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
Dihydropyrimidine Dehydrogenase Deficiency [MESH:D054067] (88) |
|
|
Hypomagnesemia 4, Renal [MESH:C567127] (225) |
|
|
Pseudohypoaldosteronism [MESH:D011546] (232) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
Cortisone reductase deficiency [MESH:C536447] (136) |
|
|
Ichthyosis, X-Linked [MESH:D016114] (91) |
|
|
Mitochondrial Complex III Deficiency [MESH:C565128] (54) |
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
|
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
|
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
|
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
|
|
|
Mandibuloacral dysplasia with type A lipodystrophy [MESH:C535705] (490) |
|
|
HIV-Associated Lipodystrophy Syndrome [MESH:D039682] (91) |
|
|
Lipodystrophy, Familial Partial [MESH:D052496] (589) |
|
|
|
|
|
Porphyria Cutanea Tarda [MESH:D017119] (766) |
|
|
HIV Wasting Syndrome [MESH:D019247] (1956) |
|
|
Hypercalcemia [MESH:D006934] (1999) |
|
|
|
|
|
|
|
|
Protein Deficiency [MESH:D011488] (1057) |
|
|
Vitamin A Deficiency [MESH:D014802] (705) |
|
|
Hyperhomocysteinemia [MESH:D020138] (1716) |
|
|
Ataxia with vitamin E deficiency [MESH:C535393] (271) |
|
|
|
|
|
Obesity, Morbid [MESH:D009767] (515) |
|
|
HIV Wasting Syndrome [MESH:D019247] (1956) |
|
 |
C19. Endocrine System Diseases |
 |
 |
|
C19. Endocrine System Diseases |
|
|
Endocrine-Cerebroosteodysplasia [MESH:C567210] (26) |
|
|
|
|
|
|
|
|
|
|
|
Adrenocortical Carcinoma, Hereditary [MESH:C565972] (769) |
|
|
|
|
|
|
|
|
Adrenocortical Carcinoma, Hereditary [MESH:C565972] (769) |
|
|
Adrenoleukodystrophy [MESH:D000326] (1348) |
|
|
Diabetes, Gestational [MESH:D016640] (1152) |
|
|
Diabetes Mellitus, Experimental [MESH:D003921] (4771) |
|
|
Diabetes Mellitus, Type 2 [MESH:D003924] (4219) |
|
|
Diabetic Cardiomyopathies [MESH:D058065] (1995) |
|
|
Diabetic Nephropathies [MESH:D003928] (2301) |
|
|
Diabetic Neuropathies [MESH:D003929] (2443) |
|
|
Diabetic Retinopathy [MESH:D003930] (1371) |
|
|
Wolcott-Rallison syndrome [MESH:C536739] (92) |
|
|
Rapadilino syndrome [MESH:C535288] (30) |
|
|
Laron Syndrome [MESH:D046150] (91) |
|
|
Short Stature, Idiopathic, Autosomal [MESH:C565805] (194) |
|
|
Pituitary Neoplasms [MESH:D010911] (981) |
|
|
|
|
|
|
|
|
Adrenocortical Carcinoma, Hereditary [MESH:C565972] (769) |
|
|
Multiple Endocrine Neoplasia, Type IV [MESH:C567059] (297) |
|
|
Hereditary Breast and Ovarian Cancer Syndrome [MESH:D061325] (143) |
|
|
Pancreatic cancer, adult [MESH:C535836] (572) |
|
|
Melanoma-Pancreatic Cancer Syndrome [MESH:C563985] (159) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
Testicular Germ Cell Tumor [MESH:C563236] (176) |
|
|
Thyroid cancer, anaplastic [MESH:C536910] (489) |
|
|
Thyroid cancer, papillary [MESH:C536915] (111) |
|
|
Puberty, Delayed [MESH:D011628] (449) |
|
|
Puberty, Precocious [MESH:D011629] (1147) |
|
|
|
|
|
Cortisone reductase deficiency [MESH:C536447] (136) |
|
|
Aromatase deficiency [MESH:C537436] (277) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
|
Denys-Drash Syndrome [MESH:D030321] (57) |
|
|
Frasier Syndrome [MESH:D052159] (57) |
|
|
WAGR Syndrome [MESH:D017624] (270) |
|
|
Meacham Winn Culler syndrome [MESH:C538162] (57) |
|
|
Sexual Infantilism [MESH:D050035] (277) |
|
|
Meacham Winn Culler syndrome [MESH:C538162] (57) |
|
|
Sexual Infantilism [MESH:D050035] (277) |
|
|
Chondrodysplasia, acromesomelic, with genital anomalies [MESH:C537913] (20) |
|
|
Primary Ovarian Insufficiency [MESH:D016649] (270) |
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
Hereditary Breast and Ovarian Cancer Syndrome [MESH:D061325] (143) |
|
|
Cryptorchidism [MESH:D003456] (215) |
|
|
Testicular Germ Cell Tumor [MESH:C563236] (176) |
|
|
|
|
|
Hyperparathyroidism, Secondary [MESH:D006962] (1138) |
|
|
|
|
|
DiGeorge Syndrome [MESH:D004062] (236) |
|
|
Pituitary Neoplasms [MESH:D010911] (981) |
|
|
Hyperprolactinemia [MESH:D006966] (603) |
|
|
|
|
|
Short Stature, Idiopathic, Autosomal [MESH:C565805] (194) |
|
|
Thyrotoxicosis [MESH:D013971] (93) |
|
|
|
|
|
Graves Ophthalmopathy [MESH:D049970] (165) |
|
|
Thyrotoxicosis [MESH:D013971] (93) |
|
|
Graves Ophthalmopathy [MESH:D049970] (165) |
|
|
Thyroid cancer, anaplastic [MESH:C536910] (489) |
|
|
Thyroid cancer, papillary [MESH:C536915] (111) |
|
 |
C20. Immune System Diseases |
 |
 |
|
C20. Immune System Diseases |
|
|
Graft vs Host Disease [MESH:D006086] (674) |
|
|
Arthritis, Juvenile [MESH:D001171] (1060) |
|
|
Arthritis, Rheumatoid [MESH:D001172] (3601) |
|
|
Autoimmune Lymphoproliferative Syndrome [MESH:D056735] (704) |
|
|
Glomerulonephritis, IGA [MESH:D005922] (897) |
|
|
Hepatitis, Autoimmune [MESH:D019693] (1982) |
|
|
Pemphigoid, Bullous [MESH:D010391] (707) |
|
|
Myasthenia Gravis [MESH:D009157] (632) |
|
|
Uveomeningoencephalitic Syndrome [MESH:D014607] (39) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
Neuromyelitis Optica [MESH:D009471] (248) |
|
|
Encephalomyelitis, Autoimmune, Experimental [MESH:D004681] (806) |
|
|
Wolcott-Rallison syndrome [MESH:C536739] (92) |
|
|
Graves Ophthalmopathy [MESH:D049970] (165) |
|
|
Lupus Nephritis [MESH:D008181] (602) |
|
|
|
|
|
Asthma, Aspirin-Induced [MESH:D055963] (1055) |
|
|
Drug Eruptions [MESH:D003875] (2695) |
|
|
Dermatitis, Allergic Contact [MESH:D017449] (3241) |
|
|
Anaphylaxis [MESH:D000707] (299) |
|
|
Asthma, Aspirin-Induced [MESH:D055963] (1055) |
|
|
Dermatitis, Atopic, 4 [MESH:C565291] (130) |
|
|
Peanut Hypersensitivity [MESH:D021183] (572) |
|
|
Ige Responsiveness, Atopic [MESH:C564133] (267) |
|
|
Alveolitis, Extrinsic Allergic [MESH:D000542] (495) |
|
|
Asthma [MESH:D001249] (3914) |
|
|
Angioedema [MESH:D000799] (837) |
|
|
Vasculitis, Leukocytoclastic, Cutaneous [MESH:D018366] (121) |
|
|
WHIM syndrome [MESH:C536697] (148) |
|
|
Neutrophil Immunodeficiency Syndrome [MESH:C564275] (47) |
|
|
LIG4 Syndrome [MESH:C564694] (24) |
|
|
MYD88 Deficiency [MESH:C567379] (79) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
Agammaglobulinemia [MESH:D000361] (156) |
|
|
Ataxia Telangiectasia [MESH:D001260] (142) |
|
|
Lymphopenia [MESH:D008231] (990) |
|
|
Acquired Immunodeficiency Syndrome [MESH:D000163] (743) |
|
|
HIV-Associated Lipodystrophy Syndrome [MESH:D039682] (91) |
|
|
HIV Wasting Syndrome [MESH:D019247] (1956) |
|
|
AIDS-related Kaposi sarcoma [MESH:C554498] (914) |
|
|
|
|
|
Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative [MESH:C565533] (111) |
|
|
Hyper-Ige Recurrent Infection Syndrome, Autosomal Dominant [MESH:C567925] (283) |
|
|
Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell -Positive, NK Cell-Negative [MESH:C563440] (79) |
|
|
Bare Lymphocyte Syndrome, Type I [MESH:C565759] (101) |
|
|
Hypergammaglobulinemia [MESH:D006942] (137) |
|
|
Autoimmune Lymphoproliferative Syndrome [MESH:D056735] (704) |
|
|
Giant Lymph Node Hyperplasia [MESH:D005871] (1013) |
|
|
Plasmacytoma [MESH:D010954] (7) |
|
|
Tumor Lysis Syndrome [MESH:D015275] (48) |
|
|
|
|
|
Leukemia, Lymphocytic, Chronic, B-Cell [MESH:D015451] (2562) |
|
|
Leukemia, Prolymphocytic, T-Cell [MESH:D015461] (2) |
|
|
Leukemia-Lymphoma, Adult T-Cell [MESH:D015459] (138) |
|
|
Leukemia, Prolymphocytic, T-Cell [MESH:D015461] (2) |
|
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma [MESH:D015452] (354) |
|
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma [MESH:D054218] (510) |
|
|
Hodgkin Disease [MESH:D006689] (1082) |
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
Lymphoma, Follicular [MESH:D008224] (1025) |
|
|
Lymphoma, Mantle-Cell [MESH:D020522] (561) |
|
|
Burkitt Lymphoma [MESH:D002051] (691) |
|
|
Lymphoma, AIDS-Related [MESH:D016483] (278) |
|
|
Lymphoma, Large B-Cell, Diffuse [MESH:D016403] (2012) |
|
|
Lymphoma, Primary Effusion [MESH:D054685] (2) |
|
|
Lymphoma, Large-Cell, Anaplastic [MESH:D017728] (420) |
|
|
Lymphoma, T-Cell, Cutaneous [MESH:D016410] (912) |
|
|
Leukemia, Plasma Cell [MESH:D007952] (11) |
|
|
Multiple Myeloma [MESH:D009101] (2765) |
|
|
Waldenstrom Macroglobulinemia [MESH:D008258] (11) |
|
|
Schnitzler Syndrome [MESH:D019873] (110) |
|
 |
C22. Animal Diseases |
 |
 |
|
C22. Animal Diseases |
|
|
Disease Models, Animal [MESH:D004195] (2058) |
|
|
Mammary Neoplasms, Animal [MESH:D015674] (2735) |
|
|
Scrapie [MESH:D012608] (462) |
|
 |
C23. Pathological Conditions, Signs and Symptoms |
 |
 |
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
Alopecia [MESH:D000505] (1383) |
|
|
Plaque, Atherosclerotic [MESH:D058226] (696) |
|
|
Muscular Atrophy [MESH:D009133] (1234) |
|
|
|
|
|
Kidney Calculi [MESH:D007669] (455) |
|
|
|
|
|
Meckel Syndrome, Type 4 [MESH:C567003] (20) |
|
|
Congenital diaphragmatic hernia [MESH:C538080] (381) |
|
|
Intervertebral disc disease [MESH:C535531] (514) |
|
|
Hepatomegaly [MESH:D006529] (1169) |
|
|
Splenomegaly [MESH:D013163] (1258) |
|
|
Hypertrophy, Left Ventricular [MESH:D017379] (1430) |
|
|
Leukoplakia, Oral [MESH:D007972] (921) |
|
|
Intestinal Polyps [MESH:D007417] (1592) |
|
|
Emphysema [MESH:D004646] (1096) |
|
|
Extravasation of Diagnostic and Therapeutic Materials [MESH:D005119] (506) |
|
|
Gliosis [MESH:D005911] (1419) |
|
|
Hemolysis [MESH:D006461] (280) |
|
|
Hyperplasia [MESH:D006965] (2463) |
|
|
Muscle Weakness [MESH:D018908] (478) |
|
|
Necrosis [MESH:D009336] (4019) |
|
|
Neointima [MESH:D058426] (814) |
|
|
Nerve Degeneration [MESH:D009410] (4061) |
|
|
Sclerosis [MESH:D012598] (224) |
|
|
Ulcer [MESH:D014456] (392) |
|
|
Atrial Fibrillation [MESH:D001281] (1053) |
|
|
Bradycardia [MESH:D001919] (1899) |
|
|
Ventricular Fibrillation [MESH:D014693] (624) |
|
|
Sinoatrial Block [MESH:D012848] (95) |
|
|
|
|
|
Torsades de Pointes [MESH:D016171] (880) |
|
|
Chromosome Breakage [MESH:D019457] (139) |
|
|
Micronuclei, Chromosome-Defective [MESH:D048629] (1013) |
|
|
Translocation, Genetic [MESH:D014178] (557) |
|
|
|
|
|
|
|
|
Chromosome 17 deletion [MESH:C538045] (769) |
|
|
Embryo Loss [MESH:D020964] (288) |
|
|
Death, Sudden, Cardiac [MESH:D016757] (168) |
|
|
Critical Illness [MESH:D016638] (296) |
|
|
Disease Progression [MESH:D018450] (2868) |
|
|
Recurrence [MESH:D012008] (830) |
|
|
Genetic Predisposition to Disease [MESH:D020022] (966) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Pitt-Hopkins syndrome [MESH:C537403] (113) |
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
|
Nephrogenic Fibrosing Dermopathy [MESH:D054989] (452) |
|
|
Keloid [MESH:D007627] (1110) |
|
|
Microsatellite Instability [MESH:D053842] (141) |
|
|
Granuloma, Respiratory Tract [MESH:D015769] (502) |
|
|
Meier-Gorlin syndrome [MESH:C538012] (133) |
|
|
LIG4 Syndrome [MESH:C564694] (24) |
|
|
Insulin-Like Growth Factor I, Resistance To [MESH:C564816] (141) |
|
|
Fetal Growth Retardation [MESH:D005317] (986) |
|
|
Shock, Hemorrhagic [MESH:D012771] (2042) |
|
|
Peptic Ulcer Hemorrhage [MESH:D010438] (553) |
|
|
Cerebral Hemorrhage [MESH:D002543] (2872) |
|
|
Subarachnoid Hemorrhage [MESH:D013345] (1081) |
|
|
|
|
|
Jaundice, Obstructive [MESH:D041781] (176) |
|
|
Neurogenic Inflammation [MESH:D020078] (2246) |
|
|
|
|
|
Shock, Septic [MESH:D012772] (1830) |
|
|
Viremia [MESH:D014766] (42) |
|
|
Endotoxemia [MESH:D019446] (1289) |
|
|
No-Reflow Phenomenon [MESH:D054318] (277) |
|
|
Amenorrhea [MESH:D000568] (817) |
|
|
|
|
|
Choroidal Neovascularization [MESH:D020256] (550) |
|
|
Anaplasia [MESH:D000708] (348) |
|
|
Neoplasm Invasiveness [MESH:D009361] (3388) |
|
|
Neoplasm Recurrence, Local [MESH:D009364] (1949) |
|
|
Neoplasm, Residual [MESH:D018365] (478) |
|
|
Cell Transformation, Neoplastic [MESH:D002471] (3389) |
|
|
Lymphatic Metastasis [MESH:D008207] (917) |
|
|
|
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Multiple Organ Failure [MESH:D009102] (1836) |
|
|
Shock, Cardiogenic [MESH:D012770] (269) |
|
|
Shock, Hemorrhagic [MESH:D012771] (2042) |
|
|
Shock, Septic [MESH:D012772] (1830) |
|
|
Aging, Premature [MESH:D019588] (66) |
|
|
Asthenia [MESH:D001247] (376) |
|
|
Chills [MESH:D023341] (644) |
|
|
Edema [MESH:D004487] (3726) |
|
|
Fatigue [MESH:D005221] (437) |
|
|
Feminization [MESH:D005262] (655) |
|
|
Hypergammaglobulinemia [MESH:D006942] (105) |
|
|
Reticulocytosis [MESH:D045262] (514) |
|
|
Fever [MESH:D005334] (2856) |
|
|
Hypothermia [MESH:D007035] (2075) |
|
|
Birth Weight [MESH:D001724] (377) |
|
|
Weight Gain [MESH:D015430] (2595) |
|
|
|
|
|
Cachexia [MESH:D002100] (2283) |
|
|
|
|
|
Obesity, Morbid [MESH:D009767] (515) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Meningism [MESH:D008580] (43) |
|
|
Seizures [MESH:D012640] (4502) |
|
|
Dystonia [MESH:D004421] (848) |
|
|
Hyperkinesis [MESH:D006948] (1799) |
|
|
Ataxia with vitamin E deficiency [MESH:C535393] (271) |
|
|
Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25) |
|
|
Fragile X Tremor Ataxia Syndrome [MESH:C564105] (25) |
|
|
|
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
Learning Disorders [MESH:D007859] (2727) |
|
|
Language Development Disorders [MESH:D007805] (351) |
|
|
Aphasia [MESH:D001037] (219) |
|
|
|
|
|
Coma [MESH:D003128] (492) |
|
|
Amnesia [MESH:D000647] (1911) |
|
|
Epileptic encephalopathy, Lennox-Gastaut type [MESH:C535500] (70) |
|
|
Pitt-Hopkins syndrome [MESH:C537403] (113) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
|
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
Muscle Weakness [MESH:D018908] (478) |
|
|
Muscular Atrophy [MESH:D009133] (1234) |
|
|
|
|
|
Hyperexplexia hereditary [MESH:C538136] (80) |
|
|
Joubert syndrome 5 [MESH:C537688] (20) |
|
|
Headache [MESH:D006261] (1417) |
|
|
Pain, Intractable [MESH:D010148] (707) |
|
|
Neuralgia, Postherpetic [MESH:D051474] (742) |
|
|
Gastroparesis [MESH:D018589] (732) |
|
|
Alternating hemiplegia of childhood [MESH:C536589] (70) |
|
|
Supranuclear Palsy, Progressive [MESH:D013494] (235) |
|
|
Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 [MESH:C567768] (50) |
|
|
|
|
|
|
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
Taste Disorders [MESH:D013651] (461) |
|
|
Tinnitus [MESH:D014012] (109) |
|
|
Hearing Loss, Bilateral [MESH:D006312] (55) |
|
|
Hearing Loss, Sudden [MESH:D003639] (56) |
|
|
Yemenite deaf-blind hypopigmentation syndrome [MESH:C536771] (17) |
|
|
Charcot-Marie-Tooth disease, Type 2J [MESH:C535417] (22) |
|
|
Griscelli syndrome type 1 [MESH:C537301] (42) |
|
|
Hyperalgesia [MESH:D006930] (3929) |
|
|
Hypesthesia [MESH:D006987] (58) |
|
|
Paresthesia [MESH:D010292] (416) |
|
|
|
|
|
Yemenite deaf-blind hypopigmentation syndrome [MESH:C536771] (17) |
|
|
Abdominal Pain [MESH:D015746] (248) |
|
|
Headache [MESH:D006261] (1417) |
|
|
Pain, Intractable [MESH:D010148] (707) |
|
|
|
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
|
Angina, Unstable [MESH:D000789] (782) |
|
|
Angina, Stable [MESH:D060050] (1702) |
|
|
Neuralgia, Postherpetic [MESH:D051474] (742) |
|
|
Abdominal Pain [MESH:D015746] (248) |
|
|
Anorexia [MESH:D000855] (854) |
|
|
Constipation [MESH:D003248] (506) |
|
|
Diarrhea [MESH:D003967] (858) |
|
|
Hyperphagia [MESH:D006963] (206) |
|
|
Nausea [MESH:D009325] (2300) |
|
|
Vomiting [MESH:D014839] (1354) |
|
|
Anoxia [MESH:D000860] (1698) |
|
|
Cough [MESH:D003371] (179) |
|
|
Hyperoxia [MESH:D018496] (694) |
|
|
Respiratory Sounds [MESH:D012135] (713) |
|
|
Pitt-Hopkins syndrome [MESH:C537403] (113) |
|
|
Pruritus [MESH:D011537] (648) |
|
|
Jaundice, Obstructive [MESH:D041781] (176) |
|
|
|
|
|
Urinary Bladder, Overactive [MESH:D053201] (530) |
|
|
Albuminuria [MESH:D000419] (2394) |
|
|
|
|
|
Cortisone reductase deficiency [MESH:C536447] (136) |
|
 |
C24. Occupational Diseases |
 |
 |
|
C24. Occupational Diseases |
|
|
Not Fully Specified [NFS] (1530) |
|
|
Dermatitis, Occupational [MESH:D009783] (311) |
|
|
Berylliosis [MESH:D001607] (2005) |
|
|
Silicosis [MESH:D012829] (1273) |
|
 |
C25. Chemically-Induced Disorders |
 |
 |
|
C25. Chemically-Induced Disorders |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Dyskinesia, Drug-Induced [MESH:D004409] (1389) |
|
|
Asthma, Aspirin-Induced [MESH:D055963] (1055) |
|
|
Drug Eruptions [MESH:D003875] (2697) |
|
|
Arsenic Poisoning [MESH:D020261] (2540) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Lead Poisoning [MESH:D007855] (515) |
|
|
Manganese Poisoning [MESH:D020149] (2214) |
|
|
Psychoses, Substance-Induced [MESH:D011605] (2053) |
|
|
Favism [MESH:D005236] (193) |
|
|
Dyskinesia, Drug-Induced [MESH:D004409] (1389) |
|
|
Favism [MESH:D005236] (193) |
|
|
Amphetamine-Related Disorders [MESH:D019969] (2858) |
|
|
Cocaine-Related Disorders [MESH:D019970] (3054) |
|
|
Marijuana Abuse [MESH:D002189] (1132) |
|
|
Psychoses, Substance-Induced [MESH:D011605] (2052) |
|
|
Substance Withdrawal Syndrome [MESH:D013375] (2956) |
|
|
Alcoholism [MESH:D000437] (1519) |
|
|
|
|
|
Hepatitis, Alcoholic [MESH:D006519] (1613) |
|
|
Liver Cirrhosis, Alcoholic [MESH:D008104] (3066) |
|
|
Morphine Dependence [MESH:D009021] (855) |
|
 |
C26. Wounds and Injuries |
 |
 |
|
C26. Wounds and Injuries |
|
|
Not Fully Specified [NFS] (2454) |
|
|
Extravasation of Diagnostic and Therapeutic Materials [MESH:D005119] (506) |
|
|
Heat Stress Disorders [MESH:D018882] (226) |
|
|
Vascular System Injuries [MESH:D057772] (2086) |
|
|
Sunburn [MESH:D013471] (52) |
|
|
Brain Injuries [MESH:D001930] (3431) |
|
|
Hip Fractures [MESH:D006620] (81) |
|
|
Hip Fractures [MESH:D006620] (82) |
|
|
Hip Fractures [MESH:D006620] (81) |
|
|
|
|
|
Hip Fractures [MESH:D006620] (82) |
|
|
Neoplasms, Radiation-Induced [MESH:D009381] (171) |
|
|
Radiation Injuries, Experimental [MESH:D011833] (2662) |
|
|
Aortic Rupture [MESH:D001019] (637) |
|
|
Spinal Cord Compression [MESH:D013117] (1800) |
|
|
Lung Injury [MESH:D055370] (1814) |
|
|
|
|
|
Brain Injuries [MESH:D001930] (3431) |
|
 |
D01. Inorganic Chemicals |
 |
 |
|
D01. Inorganic Chemicals |
|
|
|
|
|
Boronic Acids [MESH:D001897] (94) |
|
|
Boronic Acids [MESH:D001897] (94) |
|
 |
D02. Organic Chemicals |
 |
 |
|
D02. Organic Chemicals |
|
|
|
|
|
Boronic Acids [MESH:D001897] (94) |
|
 |
D03. Heterocyclic Compounds |
 |
 |
|
D03. Heterocyclic Compounds |
|
|
|
|
|
Pyrazines [MESH:D011719] (369) |
|
 |
D27. Chemical Actions and Uses |
 |
 |
|
D27. Chemical Actions and Uses |
|
|
|
|
|
Antineoplastic Agents [MESH:D000970] (319) |
|
 |
E. Analytical, Diagnostic and Therapeutic Techniques and Equipment |
 |
 |
|
E. Analytical, Diagnostic and Therapeutic Techniques and Equipment |
|
|
|
|
|
|
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Pitt-Hopkins syndrome [MESH:C537403] (113) |
|
|
Trichorhinophalangeal Syndrome, Type III [MESH:C566033] (24) |
|
 |
F. Psychiatry and Psychology |
 |
 |
|
F. Psychiatry and Psychology |
|
|
|
|
|
|
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
Epileptic encephalopathy, Lennox-Gastaut type [MESH:C535500] (70) |
|
|
Pitt-Hopkins syndrome [MESH:C537403] (113) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
|
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
Spongiform Encephalopathy with Neuropsychiatric Features [MESH:C564678] (98) |
|
|
|
|
|
|
|
|
Huntington Disease-Like 1 [MESH:C566398] (98) |
|
|
|
|
|
Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia [MESH:C564330] (56) |
|
|
|
|
|
Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia [MESH:C563476] (57) |
|
|
Huntington Disease-Like 1 [MESH:C566398] (98) |
|
|
Parkinson Disease 4, Autosomal Dominant Lewy Body [MESH:C565324] (136) |
|
|
|
|
|
Epileptic encephalopathy, Lennox-Gastaut type [MESH:C535500] (70) |
|
|
Pitt-Hopkins syndrome [MESH:C537403] (113) |
|
|
Cerebrooculofacioskeletal Syndrome 2 [MESH:C565185] (48) |
|
|
|
|
|
|
|
|
Cortisone reductase deficiency [MESH:C536447] (136) |
|
|
Aromatase deficiency [MESH:C537436] (277) |
|
|
Pseudovaginal Perineoscrotal Hypospadias [MESH:C535830] (59) |
|
 |
G. Phenomena and Processes |
 |
 |
|
G. Phenomena and Processes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chromosome 17 deletion [MESH:C538045] (769) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chromosome 17 deletion [MESH:C538045] (769) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chromosome 17 deletion [MESH:C538045] (769) |
|
|
|
|
|
|
|
|
|
|
|
Chromosome 17 deletion [MESH:C538045] (769) |
|
|
|
|
|
Chromosome 17 deletion [MESH:C538045] (769) |
|
|
|
|
|
|
|
|
|
|
|
Chromosome 17 deletion [MESH:C538045] (769) |
|
 |